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ABSTRACT
Voltage-gated potassium channels are primary determinants of cellular
excitability in the mammalian nervous system. The localization of these channels to
distinct cellular compartments influences components of neuronal function, including
resting membrane potential, action potential characteristics and neurotransmitter release.
Thus, understanding the mechanistic basis of ion channel localization can provide
fundamental insight into human physiology. The overall goal of this dissertation was to
elucidate the regulatory mechanisms governing localization and function of the Kv1.3
voltage-gated potassium channel.
The sympathetic branch of the autonomic nervous system innervates many organ
systems including the kidneys, heart and blood vessels and was used as a model to study
endogenous Kv1.3. We found that postganglionic sympathetic neurons express Kv1.3
and that the channel exhibits a striking pattern of localization to the Golgi apparatus in
the soma of these cells. Kv1.3 ionic current was also isolated from the soma of these
neurons, indicating the channel is a determinant of the electrophysiological properties of
sympathetic neurons. In addition, the specific inhibition of Kv1.3 with margatoxin was
found to depolarize neuronal resting membrane potential, decrease the latency to action
potential firing and increase nicotinic agonist-induced neurotransmitter release.
Collectively, these findings demonstrate that Kv1.3 influences the function of
postganglionic sympathetic neurons and led to the hypothesis that regulating channel
localization may be a mechanism for modulating the activity of these cells.
In this dissertation, we propose that the observed Golgi retention of Kv1.3 may be
a trafficking-dependent mechanism of channel regulation. To test this hypothesis, we
used HEK293 cells as our model system. Our data show that the degree of Kv1.3 Golgi
localization is inversely correlated with the amount of channel at the plasma membrane.
In addition, the amplitude of Kv1.3 ionic current measured in cells with low Kv1.3 Golgi
localization was significantly greater than the current measured in cells with high Kv1.3
Golgi localization. One mechanism for localizing ion channels to the Golgi apparatus
involves the Class I PDZ-binding motif (X-S/T-X-Φ). Deletion of the C-terminal PDZbinding motif of Kv1.3 decreased the intracellular Golgi localization of the channel and
increased channel localization at the cell surface. Disrupting this canonical binding motif
also increased the amplitude of Kv1.3 ionic current. These findings indicate that
regulated subcellular distribution of the channel may be a determinant of Kv1.3 surface
expression and function.
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW

I. Introduction

Ion channels are integral membrane proteins that mediate rapid changes in the
electrical potential across cellular membranes (Katz and Miledi, 1970). These pore
forming proteins open and close in response to specific stimuli and selectively allow the
passage of ions through the lipid bilayer along their electrochemical gradient (Mullins,
1975). Consequently, ion channels are major determinants of cellular excitability (Schauf
and Bullock, 1979). In neurons, the complex spatial distribution of these proteins to
specific subcellular compartments such as the soma, axons, dendrites and presynaptic
terminals influences neuronal excitability and synaptic transmission (Chiu and Ritchie,
1981; Rasband et al., 1998). Therefore, understanding the mechanisms governing ion
channel localization can provide insight into neuronal function.
This dissertation identifies the novel localization of the Kv1.3 voltage-gated
potassium channel in sympathetic neurons of the autonomic nervous system. We propose
that subcellular localization of Kv1.3 to the Golgi apparatus may be a mechanism of
channel regulation. While trafficking-dependent mechanisms of regulation have been
defined for other Kv1 family channels (Choi et al., 2005; Connors et al., 2008; Nesti et
al., 2004; Watanabe et al., 2007; Zhu et al., 2003a), localization of Kv1.3 to the Golgi
remains unexplored. One major mechanism for localizing ion channels to specific
subcellular compartments involves protein-protein interactions (Gu et al., 2003; Kim et
al., 1995; Manganas and Trimmer, 2004). The work presented here identifies a protein
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interaction motif that contributes to the localization of Kv1.3 and shows that modulating
this motif can alter channel function.
The consequences of altering Kv1.3 channel function span a wide range of
physiological processes, from immune responsiveness to olfaction (Beeton et al., 2006;
Desir, 2005; Fadool et al., 2004; Rangaraju et al., 2009; Xu et al., 2003; Xu et al., 2004).
This dissertation highlights the novel expression of Kv1.3 in postganglionic sympathetic
neurons and suggests that modulating channel localization in this cell type may lead to
changes in sympathetic excitability. Altering the distribution of Kv1.3 ion channels in
these neurons may have significant effects on regulating sympathetic effectors, defining a
new physiological role for this channel. Therefore, elucidating the critical role of ion
channel localization is imperative to understanding the mechanistic basis of neuronal
activity.

II. Anatomy and Function of the Sympathetic Nervous System

A. The Sympathetic Nervous System

Chapter 2 of this study focuses on the expression, function and modulation of the
Kv1.3 voltage-gated potassium channel, using the sympathetic division of the autonomic
nervous system as a model system. The autonomic nervous system regulates homeostatic
mechanisms, including gastrointestinal motility, reproduction, metabolic physiology and
cardiovascular function (Bornstein et al., 2004; Ito and Scher, 1981; Jones et al., 1987). It
is composed of three major subdivisions: sympathetic, parasympathetic and enteric
2

(Purves, 2001). In addition to providing tonic drive to target effectors, the sympathetic
division of the autonomic nervous system also coordinates adaptive responses to stressful
stimuli (Selye and Fortier, 1949; Purves, 2001) in an event commonly referred to as the
fight or flight response. The sympathetic nervous system originates from brainstem nuclei
and from the intermediolateral cell column of the spinal cord, where preganglionic
sympathetic cell bodies extend from the thoracic (T1) to the upper lumbar (L2 or L3)
segments (Purves, 2001).

Preganglionic sympathetic neurons innervate para- and

prevertebral ganglia located outside of the central nervous system (CNS) (Purves, 2001).
The paravertebral ganglia are situated bilaterally along the length of the vertebral column,
while prevertebral ganglia are located midline and anterior to the vertebral column
(Purves, 2001).
Postganglionic sympathetic neurons (PSNs) are derived from the neural crest and
contain cell bodies that reside in the para- and prevertebral ganglia (Le Douarin and
Teillet, 1974).

PSNs extend long, generally unmyelinated, small diameter axonal

processes outward to innervate various visceral effectors as seen in Figure 1 (Glebova
and Ginty, 2005; Wallin and Charkoudian, 2007). The superior cervical ganglion (SCG)
is a representative paravertebral ganglion composed of PSNs and has been used to study
sympathetic activity (Li and Horn, 2006; Luther and Birren, 2006). In addition to
providing sympathetic innervation to the eye, major target tissues for the SCG include the
lacrimal, submandibular and parotid glands (Li and Horn, 2006). The SCG also provides
sympathetic innervation to blood vessels (Cassaglia et al., 2008; Li and Horn, 2006).
However, the sympathetic control of blood vessels is not well understood. The distal end
of a postganglionic sympathetic axon is highly branched and contains a complex network
3

of small membranous swellings termed varicosities (Todd, 1980). These varicosities
contain

mitochondria

and

numerous

large

dense-core

and

small

dense-core

neurotransmitter containing vesicles (Devine and Simpson, 1968). They are known to be
sites of local neurotransmitter release that greatly increase communication between
sympathetic efferents and target vessels (Devine and Simpson, 1967, 1968; Jackson and
Cunnane, 2001).

4

Figure 1: Anatomy of the sympathetic nervous system in a rodent model. Schematic
representation of preganglionic (green) and postganglionic (blue) sympathetic innervation
in a mouse. Preganglionic cell bodies are located in the intermediolateral (IML) cell
column of the thoracic and lumbar spinal cord. Preganglionic fibers synapse onto
postganglionic cells bodies in sympathetic ganglia (yellow). Paravertebral ganglia, such
as the superior cervical ganglion (SCG), are situated bilaterally alongside the vertebral
column. Postganglionic sympathetic fibers directly innervate target effectors such as the
heart, kidney and blood vessels.
Glebova et al. Growth and survival signals controlling sympathetic nervous system development.
Annual Review of Neuroscience. (2005) 28, pp 191-222.
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B. Sympathetic Neurotransmission

Sympathetic ganglia from the adult mouse and rat are widely used as
experimental models because they accurately reflect the sympathetic innervation of the
vasculature in humans (Glebova and Ginty, 2005; Li and Horn, 2006). The experiments
outlined in this dissertation will focus on the SCG. Phenotypic characteristics such as
neuropeptide content, electrical properties and morphology of these ganglia have been
previously explored, making SCG neurons a powerful model system for studying
sympathetic neurons (Anderson et al., 2001a; Anderson et al., 2001b; Gibbins et al.,
2000; Li and Horn, 2006; Morris et al., 1995). The experiments presented in Chapter 2
will use PSNs from primary cultures of dissociated neonatal rat SCG. Dissociated cell
cultures grown in vitro provide the opportunity to carry out a variety of experimental
techniques in a specific population of cells that can be maintained in a tightly controlled
environment.
While preganglionic sympathetic neurons utilize acetylcholine (ACh) as their
main neurotransmitter, postganglionic sympathetic neurons are primarily adrenergic, and
utilize norepinephrine (NE) (Gibbins and Morris, 2006; Kanagy, 2005; Morales et al.,
1995), as well as various neurotransmitter peptides. NE is a catecholamine
neurotransmitter that is synthesized from the amino acid tyrosine in a series of enzymatic
steps (Kirshner, 1957). Tyrosine is converted to dihydroxyphenylalanine (L-DOPA) by
tyrosine hydroxylase (Kirshner, 1957). L-DOPA is then decarboxylated to form the
neurotransmitter dopamine via the enzyme DOPA decarboxylase (Kirshner, 1957). In the
6

final step of norepinephrine biosynthesis, dopamine-β-hydroxylase oxidizes dopamine to
form NE (Kirshner, 1957). The rate limiting enzyme in norepinephrine synthesis is
tyrosine hydroxylase (TH) and is used to confirm the presence of postganglionic
sympathetic neurons (Anderson et al., 2001b). The research presented in this dissertation
utilizes TH as a marker of postganglionic neurons. Although we focus on NE release as
the main measure of sympathetic activity, it is important to note that additional
neurotransmitters, such as neuropeptide Y and ATP, are coreleased in conjunction with
NE (Msghina et al., 1998; Wahlestedt et al., 1992). The release of NE from sympathetic
nerve terminals has previously been used to measure sympathetic nerve activity and
alterations in the release and reuptake of NE may provide insight into the function of
these cells (Kristufek et al., 1999; Msghina et al., 1998; Socci et al., 2003; Uhrenholt and
Nedergaard, 2003).

C. Electrophysiological Properties of Postganglionic Sympathetic Neurons
As described above, postganglionic sympathetic neurons communicate with target
effector organs via the release of neurotransmitters such as NE (Bennett et al., 2004;
McLachlan, 2007). Therefore, the function of these neurons is essential for maintaining
the sympathetic regulation to various tissues, including blood vessels. ACh released from
preganglionic sympathetic neurons binds to ligand-gated nicotinic receptors located in the
soma of PSNs, causing membrane depolarization of the cell to reach threshold,
generating an action potential which is conducted along the length of the postganglionic
sympathetic axon (Muscholl et al., 1973). When the action potential reaches a
7

sympathetic varicosity or synaptic terminal, voltage-gated calcium channels permit entry
of extracellular calcium into the cell and activate the release of neurotransmitters
(Muscholl et al., 1973). Therefore, knowledge of the electrophysiological properties of
PSNs is crucial to understanding the function of the sympathetic nervous system.
Postganglionic sympathetic neurons can be classified into three main categories
based on their electrophysiological discharge properties upon stimulation with a
depolarizing current: Phasic (Ph), tonic (T) and long afterhyperpolarizing (LAH) (Cassell
et al., 1986; Jamieson et al., 2003; Keast et al., 1993; McLachlan and Meckler, 1989).
Phasic neurons fire multiple bursts of action potentials transiently upon depolarization,
whereas tonic neurons fire action potentials throughout the duration of a maintained
depolarization (Cassell et al., 1986). LAH neurons discharge only once, due to the
prolonged outward current that may last several seconds (McLachlan and Meckler,
1989). These three electrophysiological classes of sympathetic neurons are predominantly
localized to different populations of ganglia (Boyd et al., 1996; Keast et al., 1993). The
paravertebral chain is home to primarily Ph neurons, while T neurons and LAH neurons
reside mainly in the inferior mesenteric ganglion and celiac ganglion, respectively
(Jamieson et al., 2003).
As is true for all neurons, electrophysiological properties of sympathetic neurons
are governed by the expression and localization of various ion channels within the cell
membrane (Arnold, 2007; Choe, 2002; Kaczmarek, 2006; Lai and Jan, 2006; Roeper and
Pongs, 1996). In particular, voltage-gated potassium channels (Kv) are fundamental
determinants of neuronal excitability. Based upon their localization within the cell, Kv
channels can have different effects on neuronal physiology and neurotransmitter release;
8

affecting depolarization properties if localized to the soma, or action potential
propagation if distributed along the axon (Lai and Jan, 2006). This dissertation focuses on
elucidating the role of the Kv1.3 ion channel in sympathetic neuronal activity, and
emphasizes the importance of subcellular localization on channel function.

III. The Kv1.3 Voltage-Gated Potassium Channel

A. Kv1 Channel Structure

Voltage-gated potassium channels (Kv) are expressed throughout the mammalian
nervous system, where they play a central role in regulating neuronal excitability via the
maintenance of resting membrane potential, integration of synaptic input, and regulation
of action potential firing (Armstrong and Hille, 1998; Catterall, 1988; Choe, 2002; Lai
and Jan, 2006). These highly conserved channels are grouped into twelve families
denoted Kv1 through Kv12 (Gutman et al., 2003). The Kv1 family of voltage-gated
potassium channels is known as the Shaker family (Jan et al., 1977). First identified in
Drosophila melanogaster, genetic mutations in the Shaker locus result in flies that
vigorously shake their legs under anesthesia due to abnormal neuronal activity (Jan et al.,
1977). The Shaker family consists of eight genes encoding distinct alpha subunit proteins,
Kv1.1 through Kv1.8 (Gutman et al., 2005). These alpha subunits can also associate in a
1:1 stoichiometry with auxiliary beta-subunits (Kvβ1-3), which can alter channel
trafficking, gating and function (Heinemann et al., 1996; Rettig et al., 1994). Functional
channels are formed when four Kv1 alpha subunits assemble as homotetramers of
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uniform subunits or as heterotetramers with other members of the Kv1 family (Shen and
Pfaffinger, 1995). Formation of heteromultimeric channels greatly enhances functional
diversity through the modulation of current conduction, as well as fine tuning channel
regulation through multiple channel trafficking pathways (Choe, 2002).
Several conserved structural regions within Kv1 channels are important for
regulating fundamental aspects of channel localization and function. These regions
include the six transmembrane domains (Yi et al., 2001), the intracellular N-terminal
tetramerization domain (Gu et al., 2003), the putative voltage sensor (Borjesson and
Elinder, 2008) and the potassium ion specific pore loop (Manganas et al., 2001b; Zhu et
al., 2005). Basic properties of Kv1 channel assembly, gating, selectivity and conductance
are governed by these structural domains (Choe, 2002; Debanne, 2004; Dodson and
Forsythe, 2004; Judge and Bever, 2006; Lai and Jan, 2006).
The work presented in this dissertation focuses on a specific member of the
Shaker family, Kv1.3. Each Kv1.3 alpha subunit is composed of six transmembrane
spanning domains, termed S1-S6 (Figure 2) (Choe, 2002). The first four transmembrane
helices enable the channel to sense and respond to changes in membrane potential
(Grottesi et al., 2005). In particular, the positively charged S4 segment serves as the
voltage sensor and detects changes in membrane potential, rendering the channel in an
open or closed state (Grottesi et al., 2005). The positive charge of the voltage sensing
domain is conferred by multiple basic arginine residues in the S4 helix (Borjesson and
Elinder, 2008). Upon membrane depolarization, conformational changes in the S4
domain lead to opening of the channel pore and the influx of potassium ions (Borjesson
and Elinder, 2008; Grottesi et al., 2005). Between segments S5 and S6 lies the selectivity
10

filter, containing the signature sequence Thr-Val-Gly-Tyr-Gly that is characteristic of the
pore loop (Doyle et al., 1998). Stereochemical checkpoints ensure the specificity of
potassium ion flow through the narrow pathway of the pore loop (Doyle et al., 1998).
The transmembrane spanning helices of Kv1.3 are flanked by cytoplasmic termini
containing protein interaction domains (Gu et al., 2003; Kosolapov et al., 2004). The
intracellular N-terminal region immediately preceding the first transmembrane helix (S1)
of Kv1.3 contains a stretch of approximately 130 amino acids that mediates the
tetramerization of four alpha subunits to form a holochannel (Gu et al., 2003; Kosolapov
et al., 2004). Accordingly, this region is referred to as the T1 tetramerization domain. In
addition to promoting the proper assembly of hetero- and homotetramers (Shen and
Pfaffinger, 1995), the T1 domain has also been shown to target Kv1.3 to the axonal
region of neurons (Rivera et al., 2005), indicating a role for this domain in both the
function and localization of Kv1 channels.

11

Figure 2: Voltage-gated
subunit of Kv1 channels
transmembrane spanning
tetramerization domain, S4
(P) lies between S5 and S6.

potassium channel alpha subunit structure. The alpha
is composed of intracellular N- and C-termini and six
domains (S1-S6). The N-terminus contains the T1
(+) is the voltage sensor, and the poor loop selectivity filter

Choe, S. Potassium Channel Structures. Nature Reviews Neuroscience. (2002) 3, pp 115-120.

B. Physiological Significance of Kv1 Channels

Voltage-gated potassium channels play a major role in regulating cellular
excitability through the delicate control of potassium ion flow across the plasma
membrane (Yi et al., 2001). These channels open and close in response to changes in
membrane potential (Borjesson and Elinder, 2008) and facilitate events such as neuronal
action potential propagation. Therefore, perturbations in Kv1 channel expression and
localization could have significant consequences on neuronal function. Through the study
of mutant channels and transgenic gene-targeted deletions, the biological importance of
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Kv1 family channels has been well characterized (Brew et al., 2007; Lopantsev et al.,
2003; Tschritter et al., 2006).
Point mutations in the Kv1.1 potassium channel gene (KCNA1) have been linked
to a rare autosomal dominant disorder in humans. Known as episodic ataxia type 1
(EA1), this channelopathy is characterized by intermittent episodes of unsteady gait,
uncoordinated movements, and involuntary muscle twitches and is frequently associated
with unprovoked epileptic seizures (Manganas et al., 2001a; Smart et al., 1998). Kv1.1null mice recapitulate these symptoms and also demonstrate increased brain growth and
megencephaly (Persson et al., 2005; Petersson et al., 2003), predominantly in the
hippocampus and ventral cortex (Almgren et al., 2007; Persson et al., 2007).
Additionally, targeted deletion of KCNA1 in mice results in the hyperexcitability of CA3
pyramidal cells, providing further evidence for high seizure susceptibility in these
animals (Lopantsev et al., 2003). Kv1.1 alpha subunits commonly co-assemble with
Kv1.2 to form heteromultimeric tetramers in neurons (Brew et al., 2007; Wang et al.,
1994). These two Kv1 subtypes are often localized to juxtaparanodal regions in
myelinated axons, where they contribute to regulating action potential propagation (Brew
et al., 2007; Lai and Jan, 2006; Rasband and Shrager, 2000). Deletion of the gene that
encodes for the Kv1.2 alpha subunit (KCNA2) also leads to spontaneous generalized
seizures in mice (Brew et al., 2007), underscoring the importance of Kv1 channels in the
maintenance of neuronal excitability.
This dissertation focuses on Kv1.3, a Shaker family potassium channel closely
related to Kv1.1 and Kv1.2. Although this channel exhibits limited expression in the
central nervous system, high levels of Kv1.3 have been detected in brain regions such as
13

the dentate gyrus of the hippocampus, the hypothalamus and the olfactory bulb (Fadool
and Levitan, 1998; Grosse et al., 2000; Veh et al., 1995). Also, Kv1.3 accounts for the
largest proportion of outward current from olfactory bulb mitral cells (Fadool et al.,
2004). Gene-targeted deletion of this channel results in neurons with modified action
potential characteristics; less current is required to elicit the same spike frequencies
observed in wild-type cells (Fadool et al., 2004). In addition, behavioral assessments
revealed that Kv1.3-null mice have a lower threshold for odor detection that is
accompanied by increased odor discrimination, suggesting a link between neuronal
excitability and behavior (Fadool et al., 2004). Conversely, recent studies indicate that a
single-nucleotide polymorphism in the human Kv1.3 gene (KCNA3) results in a gain of
function; accordingly, carriers of this polymorphism show impairments in olfactory
function (Guthoff et al., 2009).
Kv1.3 has also been highlighted as an important component of other physiological
processes. Phenotypic examination of Kv1.3 deficient mice (Kv1.3 -/-) indicates that the
channel is a determinant of body weight and energy homeostasis (Xu et al., 2003). In
comparison to control littermates, Kv1.3

-/-

mice display decreased body weight,

increased metabolic rate and are resistant to diet-induced obesity (Xu et al., 2004). Kv1.3
has also been found to contribute to the regulation of peripheral insulin sensitivity and
glucose metabolism (Xu et al., 2004). Inhibiting Kv1.3 has been shown to decrease
inflammatory cytokines, thereby increasing insulin sensitivity (Desir, 2005; Xu et al.,
2004). In addition, a polymorphism in the promoter region of human KCNA3 that alters
transcriptional activity is associated with impaired glucose tolerance and reduced insulin
sensitivity (Tschritter et al., 2006). These findings also provide rationale to explore
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Kv1.3 as a potential therapeutic target for metabolic diseases such as diabetes mellitus
(Desir, 2005; Esler et al., 2001).
Homotetrameric Kv1.3 channels are the major voltage-gated potassium channels
expressed in T-lymphocytes, key mediators of autoimmune disease (Beeton et al., 2006;
Panyi, 2005; Panyi et al., 2006; Panyi et al., 2004a). In these cells, the channel plays a
central role in regulating resting membrane potential, Ca2+ signaling cascades, and
antigen-dependent activation and proliferation (Lin et al., 1993). The expression of Kv1.3
has been shown to dramatically increase when CD4+ and CD8+ T-lymphocytes are
activated and inhibition of the channel suppresses downstream signaling cascades that
lead to cell proliferation and cytokine production (Beeton et al., 2006). This research has
placed Kv1.3 at the center of emerging therapeutic targets for T-cell mediated
autoimmune diseases (Beeton et al., 2006).

C. Kv1 Channel Pharmacology

Because a plethora of diverse ion channels exist within cellular membranes,
isolating current from voltage-gated potassium channels is a challenging task. However,
pharmacological reagents that specifically block Kv channels have been used to resolve
current from distinct channels (Garcia-Calvo et al., 1993; Kirpekar et al., 1977;
MacKinnon and Yellen, 1990; Vacher et al., 2007). In addition, these pharmacological
tools have been used to decipher the physiological role of differential channel localization
(Panyi et al., 2006). Two main molecular pharmacological agents are capable of blocking
or modulating Kv channels: organic compounds and venom-derived peptide toxins
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(Grissmer et al., 1994; Gutman et al., 2005; Judge and Bever, 2006; Wei et al., 2005).
These powerful probes have been used to investigate various Kv channel currents in a
variety of cell types.
Most potassium channels possess the ability to pass ammonium ions, however the
quaternary derivative, tetraethylammonium chloride (TEA), acts an open channel blocker
of Kv channels (Cena et al., 1985; Crouzy et al., 2001; Heginbotham and MacKinnon,
1992; MacKinnon and Yellen, 1990). While the effect of intracellular TEA is quite
uniform in blocking Kv channels, the extracellular application of TEA is variable; Kv1
channels demonstrate one of the lowest sensitivities to this organic compound, allowing
the use of TEA as a tool to resolve currents produced by these channels (MacKinnon and
Yellen, 1990).
Another organic compound, 4-aminopyridine (4-AP), blocks a variety of Kv
channels, having the greatest binding affinity for delayed rectifying channels of the Kv1
family (Judge and Bever, 2006; Kirpekar et al., 1977; Msghina et al., 1998; Przywara et
al., 1992; Thorneloe et al., 2001). This compound is known as an open channel blocker
because upon application, the drug enters the pore region of an open channel, and
becomes trapped within the intracellular face of the channel pore (Judge and Bever,
2006). Researchers report that the addition of 4-AP to rabbit carotid arteries preloaded
with [3H]-norepinephrine greatly enhances the stimulation-evoked overflow of NE,
suggesting that voltage-gated potassium channel blockade increases neurotransmitter
release from sympathetic neurons (Uhrenholt and Nedergaard, 2003). Studies of ocular
hypertension in rabbits indicate that the topical application of 4-AP can elevate
intraocular pressure (IOP) (Socci et al., 2003). Increases in IOP are accompanied by
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increases in aqueous levels of NE (Socci et al., 2003). In isolated rabbit iris-ciliary body
preparations, 4-AP causes a significant increase in field-stimulated NE release from
sympathetic nerves (Socci et al., 2003). These experiments suggest that Kv channels in
sympathetic nerves are important for regulating neurotransmitter release and provide a
rationale for isolating specific Kv1 family currents from postganglionic sympathetic
neurons.
Venom-derived peptide toxins are small, compact globular proteins that are
highly potent Kv channel inhibitors selective for specific classes of ion channels (Judge
and Bever, 2006). At low nanomolar concentrations, the snake-derived peptide toxin,
dendrotoxin (DTX), can specifically inhibit Kv1.1 and Kv1.2 channels (Dodson et al.,
2003; Gasparini et al., 1998; Haghdoust et al., 2006; Harvey, 2001; Judge and Bever,
2006). Similarly, the scorpion-derived peptide toxin, margatoxin (MgTx), can
specifically inhibit Kv1.3 at low concentrations (Bednarek et al., 1994; Garcia-Calvo et
al., 1993; Helms et al., 1997; Judge and Bever, 2006; Shah et al., 2003). While it is
possible for some venom-derived toxins to incorporate into the lipid bilayer and modulate
the voltage sensing region of potassium channels (Swartz and MacKinnon, 1995), DTX
and MgTX exert their channel blockade in a different way. These toxins bind to the
extracellular mouth of the pore region, blocking the flow of potassium ions through the
channel (Judge and Bever, 2006). The experiments outlined in this dissertation use both
DTX and MgTX as pharmacological tools to specifically isolate endogenous
Kv1.1/Kv1.2 and Kv1.3 currents, respectively. While venom-derived toxins used at
specific concentrations are useful for blocking Kv1 currents, strong sequence homology
of these channels may preclude toxin specificity in some instances. Therefore it is
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important to note that additional molecular approaches such as RNA interference or
transgenic knockouts may be needed to fully validate the scientific findings resulting
from toxin blockade.

D. Kv1.3 Regulation

Voltage-gated potassium channels are subject to multiple mechanisms of
regulation (Figure 3). Transcriptional regulation of Kv channels influences membrane
excitability by up- or downregulating the amount of available channel protein within a
given cell (Guthoff et al., 2009; Tschritter et al., 2006). Functional diversity is also
regulated at various checkpoints within the biosynthetic pathway. At the level of
translation, assembly of homo- or heterotetramers occurs in the ER and the ratio of
subunit expression influences channel regulation (Kerr et al., 2001; Vicente et al., 2008).
Primary amino acid motifs within the channel protein itself commonly control export
from and retention in the ER (Li et al., 2000; Ma and Jan, 2002). Trafficking through the
Golgi apparatus also serves as a locus for regulation; N-linked glycosylation of Kv1
family channels in the Golgi is required for efficient plasma membrane expression
Khanna et al., 2001; Zhu et al., 2001; Zhu et al., 2003). Once in the plasma membrane,
select ion channels undergo local trafficking events such as endocytosis and recycling
(Nesti et al., 2004), shuttling them away from and back into the cell membrane. Many of
these regulatory events are mediated by direct chemical modification of the protein,
known as post-translational modification.
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Figure 3: Voltage-gated potassium channel regulation. Kv1 channels are subject to
multiple regulatory mechanisms, which occur in various cellular compartments such as
the nucleus, endoplasmic reticulum (ER), Golgi apparatus, and plasma membrane.
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Post-translational modification events play a key role in regulating the function of
many voltage-gated ion channels (Catterall, 1988). Early studies reported that Kv1.3
current was functionally regulated via manipulation of protein kinase A (PKA) and
protein kinase C (PKC) (Cai and Douglass, 1993). These findings, coupled with evidence
that Kv1.3 can be directly phosphorylated at specific sites, led to speculation that
serine/threonine phosphorylation was the major mechanism of Kv1.3 regulation in cell
types as diverse as T-lymphocytes and Xenopus oocytes (Attali et al., 1992; Payet and
Dupuis, 1992). Studies involving other Kv1 channels also demonstrate that PKA and
PKC alter single channel properties and current conductance, providing further evidence
that serine/threonine phosphorylation plays a key role in Kv1 channel regulation (Huang
et al., 1994; Tsai et al., 1997).
In addition to extensive studies on serine/threonine phosphorylation of ion
channels, the direct phosphorylation of tyrosine residues has also emerged as a key
mechanism of channel regulation (Huang et al., 1993). In 1993, Huang et al found that
the activity of Kv1.2 is modulated by tyrosine phosphorylation; m1 muscarinic
acetylcholine receptor activation induced tyrosine phosphorylation of specific residues
led to a suppression of Kv1.2 ionic current, without altering channel kinetics (Huang et
al., 1993). Later studies determined that the mechanism of Kv1.2 current suppression was
a physical removal of the channel from the plasma membrane known as endocytosis
(Nesti et al., 2004). These findings were the first to link tyrosine phosphorylation
dependent signaling to cellular excitability via the trafficking-dependent regulation of a
voltage-gated potassium channel.
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Following this seminal discovery, tyrosine phosphorylation of other ion channels
has become an area of considerable interest (Holmes et al., 1996; MacFarlane and
Sontheimer, 2000; Wang, 1999). Kv1.3 also contains multiple tyrosine residues that lie
within potential consensus sites for tyrosine kinase-mediated phosphorylation (Figure 4).
In 1996, Holmes et al published the first report of tyrosine phosphorylation modulating
the functional properties of Kv1.3. This study showed that pharmacological inhibition of
tyrosine

phosphatase

activity

via

pervanadate

application,

increased

tyrosine

phosphorylation of Kv1.3 in a dose-dependent manner (Holmes et al., 1996). This
increase in Kv1.3 tyrosine phosphorylation was also accompanied by a concomitant
suppression of Kv1.3 ionic current that was eliminated by introducing a single point
mutation (Y449F) (Holmes et al., 1996). These data provided the first evidence that
direct phosphorylation of Kv1.3 is associated with functional suppression of ionic current
(Holmes et al., 1996).
Since the initial discovery that phosphorylation suppresses Kv1.3 current, both
cellular and receptor tyrosine kinases have been found to alter the functional properties of
Kv1.3 (Colley et al., 2004; Fadool et al., 1997; Marks and Fadool, 2007). Coexpression
of Kv1.3 with the constitutively active nonreceptor tyrosine kinase, v-Src, suppresses
channel current (Fadool et al., 1997). In addition, brain derived neurotrophic factor
(BDNF)-induced activation of neurotrophin receptor tyrosine kinase B (TrkB) results in
putative phosphorylation of multiple tyrosine residues on both the N- and C-terminus of
Kv1.3 and is accompanied by suppression of current magnitude in rat olfactory bulb
neurons (Colley et al., 2004). Similarly, insulin-induced neuromodulation of Kv1.3
occurs through insulin receptor (IR) kinase activity at specific tyrosine residues (Marks
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and Fadool, 2007). While several physiological stimuli suppress Kv1.3 ionic current in a
tyrosine phosphorylation dependent manner (Colley et al., 2004; Fadool et al., 1997;
Marks and Fadool, 2007), the exact mechanism of functional suppression remains largely
unexplored.
Major advancements in understanding the function and regulation of Kv1.3 were
achieved by studying mice with a gene-targeted deletion of the channel (Biju et al., 2008;
Fadool et al., 2004; Tucker et al., 2008). Along with post-translational modifications,
protein-protein interactions have also been found to regulate Kv1.3 function (Fadool et
al., 2004; Marks and Fadool, 2007). The expression of various modulatory kinases and
scaffolding proteins normally associated with the channel was greatly altered in Kv1.3
null mice (Fadool et al., 2004). In addition to both the cellular kinase, Src, and the
receptor tyrosine kinase, TrkB, Kv1.3-null mice also exhibited upregulation of the
synaptic adaptor protein, post-synaptic density 95 (PSD-95) (Fadool et al., 2004). A
recent study demonstrated that PSD-95 clusters Kv1.3 channels in specific membrane
microdomains and significantly suppresses current magnitude of these channels via an
activity-dependent mechanism (Marks and Fadool, 2007). These findings indicate a role
for adaptor proteins in modulating the localization and function of voltage-gated
potassium channels (Marks and Fadool, 2007).
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Figure 4: The primary structure of Kv1.3 contains multiple regulatory motifs. The
cytoplasmic N- and C-termini, as well as the poor loop region of Kv1.3, contain multiple
tyrosine residues (•) that lie within consensus sequences for phosphorylation by Src
kinase (*), TrkB (#), and insulin receptor kinase (+). In addition, Kv1.3 contains two
proline rich domains (PXXP) which may bind SH3 domain containing proteins. The
extreme C-terminus of Kv1.3 contains a consensus sequence (X-(S/T)-X-φ) known to
bind PDZ domain containing proteins, such as the canonical PDZ protein, PSD-95.
Colley et al. Brain-derived neurotrophic factor modulation of Kv1.3 channel is disregulated by
adapter proteins Grb10 and nShc. BMC Neuroscience. (2009) 10:8.
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IV. PDZ Domain Interactions

A. Structural Basis of PDZ Domain Recognition

Similar to many other ion channels, Kv1.3 contains a consensus sequence for the
binding of PDZ domain containing proteins (Kim et al., 1995). Often arranged in tandem
arrays or in conjunction with other interaction domains, PDZ domains are protein-protein
recognition modules that can assemble large molecular complexes and participate in
diverse signaling assemblies (Feng and Zhang, 2009; Harris and Lim, 2001; Kim and
Sheng, 2004). These domains were originally discovered as homologous regions in
diverse signaling proteins (Cho et al., 1992; Woods and Bryant, 1993). The name PDZ is
an acronym derived from the first three proteins in which these domains were found:
postsynaptic density-95 (PSD-95), discs-large (DLG) and zona-occludens-1 (ZO-1)
(Harris and Lim, 2001; Jemth and Gianni, 2007). As depicted in Figure 5, PDZ domains
are composed of approximately 90 amino acid residues, folded into six beta sheets (βAβF) and two alpha helices (αA, αB), forming an extended groove between strand βB and
helix αB (Harris and Lim, 2001; Jemth and Gianni, 2007). This groove recognizes
specific PDZ-binding motifs, also referred to as PDZ ligands, found at the extreme
carboxyl-terminus of transmembrane receptors and ion channels (Harrison, 1996). A
highly conserved four residue sequence in the carboxylate-binding loop of the extended
groove, known as the signature Gly-Leu-Gly-Phe (GLGF) motif, forms hydrogen bonds
with the PDZ ligand (Morais Cabral et al., 1996). The extended groove binds the
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consensus sequence of the PDZ ligand with varying affinity based on preferential residue
specificity (Harris and Lim, 2001).
PDZ domain recognition specificity is dictated by the primary amino acid
sequence of the C-terminal PDZ-binding motif that binds in the extended groove
(Songyang et al., 1997). Consensus binding sequences are divided into three main
categories, defined as Class I (X-(S/T)-X-φ-COOH), Class II (X-φ-X-φ-COOH) and
Class III (X-X-C-COOH) (Songyang et al., 1997). With the exception of internal βhairpin folds, as seen in the binding of neuronal nitric oxide synthase (nNOS) to
syntrophin (Christopherson et al., 1999), virtually all PDZ domains recognize terminal
carboxyl motifs (Christopherson et al., 1999; Harris and Lim, 2001; Hillier et al., 1999;
Trejo, 2005). Even in the case of this internal PDZ motif recognition, the same energetic
requirements observed in C-terminal binding are maintained because the tertiary structure
of the internal loop mimics a chain terminus (Gee et al., 1998). The nomenclature of
these terminal residues is well established; the C-terminal amino acid is termed P0, while
upstream N-terminal residues are termed P-1, P-2, P-3, etc (Harris and Lim, 2001). Studies
suggest that residues in the P0 and P-2 position are most important for proper PDZ domain
recognition and serve as critical docking sites in the binding groove (Jelen et al., 2003;
Sheng and Sala, 2001).
Other residues in the PDZ binding motif may confer specificity and serve to fine
tune the PDZ interaction (Harris and Lim, 2001). The amino acid residue located at the
P-3 position also makes contact with the PDZ domain, and has been shown to participate
in hydrogen bonding of the ligand with the groove (Sheng and Sala, 2001). Ionotropic
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glutamate receptors (NMDA), voltage-gated sodium channels, and some Shaker
potassium channels contain a glutamate residue at the P-3 position that may be involved in
mediating the selectivity of PDZ domain protein interactions (Songyang et al., 1997). In
the case of Kv1.3, P-3 is occupied by phenylalanine, a nonpolar hydrophobic residue
containing a benzyl side chain. It is the only member of the Shaker family that does not
contain either a glutamate or leucine residue at this position (Kim et al., 1995) and
therefore may be recognized by PDZ domain proteins distinct from other Kv1 channels.
Moreover, the localization of Kv1.3 may be regulated by specific PDZ interactions that
are distinct from other Kv1 family channels.
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Figure 5: The tertiary structure of PDZ domains. PDZ domains are composed of
approximately 90 amino acids forming six beta strands (βA-βF; blue) and two alpha
helices (αA, αB; green). Between beta strand B and alpha helix B lies the extended
groove, which binds the extreme C-terminal PDZ ligand (purple) of transmembrane
receptors and ion channels.
Kim et al. PDZ domain proteins of synapses. Nature Reviews Neuroscience. (2004) 5, pp 771-781.

B. Role of PDZ Interactions in Protein Localization

The localization of proteins to distinct cellular compartments strongly influences
cellular function. Perhaps the most fundamental demonstration of the role PDZ domain
containing proteins play in compartmental localization is exemplified by the process of
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polarized signaling. For example, the plasma membrane of epithelial cells is divided into
apical and basolateral surfaces, which are separated by tight junctions (Kim, 1997;
Mostov et al., 2003). Maintenance of this cell polarity is crucial for normal cellular
function and is facilitated by the asymmetrical distribution of receptors, transporters and
ion channels between these membranes (Kim, 1997; Mostov et al., 2003; Moyer et al.,
1999). PDZ domains are essential components in determining this cellular polarity; they
have been shown to specifically localize proteins to both the apical and basolateral
membranes (Fanning and Anderson, 1999).
Neurons also have a highly polarized cellular structure, most often composed of
somatic, dendritic and axonal compartments (Dotti et al., 1988). Several studies have
shown that PDZ domain interactions are integral for anchoring proteins at specific
subcellular sites (Harris and Lim, 2001; Kim et al., 1995). These molecular scaffolds help
maintain the specific protein localization required for neuronal signaling (Kim et al.,
1995; Srivastava et al., 1998). Spatial restriction of Kv1 channels to the axon initial
segment of neurons is mediated by a macromolecular protein complex involving postsynaptic density 93 (PSD-93) (Ogawa et al., 2008). In addition, PSD-95 has been shown
to cluster Kv1 channels in heterologous cells (Kim et al., 1995; Marks and Fadool, 2007),
as well as differentially recruit these channels into neuronal lipid rafts (Wong and
Schlichter, 2004), providing further evidence for the role of PDZ domains in protein
localization.
Altering interactions with the C-terminal PDZ binding motif of ion channels leads
to significant changes in their localization and function (Haggie et al., 2004; Nehring et
al., 2000; Roche et al., 2001). For example, association of an inward rectifier potassium
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channel, Kir2.3, with PSD-95 functionally suppresses the activity of the channel by
reducing its single channel conductance (Nehring et al., 2000). Deleting the PDZ binding
motif of the NR2B subunit of the ionotropic glutamate receptor, N-methyl-D-aspartate
(NMDA), results in channel internalization from the plasma membrane (Roche et al.,
2001). Furthermore, removing the PDZ binding motif of the Cystic Fibrosis
transmembrane conductance regulator (CFTR) disrupts the normal intracellular
trafficking of the channel, underscoring the importance of this motif in protein
localization and function (Haggie et al., 2004).
Minimal evidence exists for defining the role of the Kv1.3 C-terminal PDZbinding motif in regulating the localization and function of this channel. Early studies
have demonstrated that similar to other Kv1 channels, the C-terminal tail of Kv1.3
associates with PSD-95 (Kim et al., 1995). Subsequent analyses of Kv1.3-null mice have
shown that deletion of the channel alters the expression of various scaffolding proteins,
including PSD-95 (Fadool et al., 2004). These findings are consistent with previous
observations of the reciprocal regulation of Kv1.3 (Holmes et al., 1997). While Src
kinase has been shown to suppress Kv1.3 current, the overexpression of Kv1.3
downregulates Src (Holmes et al., 1997).

A recent study identified the functional

ramifications of coexpressing Kv1.3 and PSD-95 in a heterologous system (Marks and
Fadool, 2007). Co-immunoprecipitation of Kv1.3 and PSD-95 is dependent on the
presence of specific C-terminal residues; phosphorylation-independent point mutations in
the PDZ-binding motif of Kv1.3 disrupted the channel/adapter complex (Marks and
Fadool, 2007). While molecular interaction of the Kv1.3 C-terminal PDZ binding motif
with PSD-95 is responsible for channel clustering in the plasma membrane, the PSD-95
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mediated decrease in the activity-dependent peak current magnitude of Kv1.3 relies on
domain interactions beyond canonical PDZ binding (Marks and Fadool, 2007). The work
presented in this dissertation is the first to identify a role for the PDZ-binding motif in
Golgi localization of Kv1.3 and aims to elucidate the functional consequences of
abolishing this protein interaction motif.

C. PDZ Interactions and the Golgi Apparatus

Intracellular localization and trafficking are distinct properties that have been
shown to extensively influence ion channel function (Gu et al., 2003; Nesti et al., 2004).
PDZ domains have been shown to contribute to the localization of proteins to
intracellular organelles, such as the Golgi apparatus (Gentzsch et al., 2003; Guggino,
2004; He et al., 2004). Several ion channels are known to localize to the Golgi apparatus
(Cheng et al., 2002; Gentzsch et al., 2003; Zhu et al., 2001). Analysis of the intracellular
distribution of other Kv1 family channels reveals that Kv1.4 accumulates in the Golgi,
whereas Kv1.1 and Kv1.2 are primarily found in the ER (Zhu et al., 2001, 2003a). The
CFTR associates with a Golgi resident protein presumed to tether CFTR to this organelle
and potentially regulate channel transit to the plasma membrane (Cheng et al., 2002;
Guggino, 2004). Another chloride channel, ClC-3B, also localizes to the Golgi apparatus
and has been found to associate with the same Golgi resident proteins as CFTR (Gentzsch
et al., 2003).
Biosynthetic trafficking is an important mechanism for determining the level of
mature protein within a cell and can be regulated at multiple stages (Ma and Jan, 2002;
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Ma et al., 2001). Although many motifs exist for modulating endoplasmic reticulum (ER)
retention and export (Zarei et al., 2004; Zhu et al., 2003a), the Golgi apparatus also
appears to serve as a checkpoint for anterograde protein trafficking (Cheng et al., 2002;
Gentzsch et al., 2003; He et al., 2002). Glycosylation in the Golgi apparatus is a major
determinant of protein trafficking to the plasma membrane (He et al., 2002; Watanabe et
al., 2007; Zhu et al., 2001). For example, a glycosylation-deficient mutant of the beta 1
adrenergic receptor (β1AR) leads to functional protein production, but decreased receptor
surface expression (He et al., 2002). Analysis of the intracellular distribution of Kv1
family channels reveals that Kv1.4 accumulates in the Golgi and illustrates a role for
trans-Golgi glycosylation in the surface expression of Kv1 channels (Watanabe et al.,
2007; Zhu et al., 2001).
In addition, protein-protein interactions in the Golgi apparatus also regulate
biosynthetic trafficking (Cheng et al., 2002; Gentzsch et al., 2003; He et al., 2004). For
example, CFTR channels interact with the Golgi-associated protein, CFTR-associated
ligand (CAL) (Cheng et al., 2002). Overexpression of CAL significantly reduces CFTR
surface expression and ionic current by potentially sequestering the channel to the Golgi,
an interaction mediated by the C-terminal PDZ-binding motif of the channel (Cheng et
al., 2002). Since the discovery of CAL, this PDZ domain protein has been found to
interact with other ion channels in the Golgi apparatus (Gentzsch et al., 2003). The ClC3B chloride channel is present primarily in the Golgi, where it also associates with CAL,
alternatively known as Golgi-associated PDZ and coiled-coil motif containing protein
(GOPC) (Gentzsch et al., 2003). Finally, the carboxyl terminus of β1AR, which contains
a PDZ-binding motif, also associates with CAL (He et al., 2004). Overexpression of CAL
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results in an intracellular accumulation of β1AR, which is accompanied by a concurrent
decrease in cell surface receptor (He et al., 2004). This dissertation identifies the Kv1.3
voltage gated potassium channel as being enriched in the Golgi apparatus and explores
the role of the PDZ-binding motif in this subcellular localization.

V. Summary
The investigations associated with this project have focused on the function and
regulation of the Kv1.3 voltage-gated potassium channel. Chapter 2 presents novel
evidence indicating that Kv1.3 is a determinant of postganglionic sympathetic neuronal
function. Inhibition of the channel alters resting membrane potential, latency to action
potential firing, and neurotransmitter release in these cells. Before Chapter 2 was
published in the American Journal of Physiology, Kv1 mRNAs were known to be
expressed within sympathetic ganglia (Dixon and McKinnon, 1996), but little was
understood about the location or function of specific Kv1 channels in these neurons. In
this chapter, we also show that Kv1.3 exhibits a striking pattern of localization to a
discrete intracellular compartment, overlapping with a marker for the Golgi apparatus.
Not only did this research establish the importance of Kv1.3 in sympathetic neuronal
function, it also unlocked the possibility that Golgi retention of Kv1.3 may play a role in
regulating the functional properties of these neurons.
The remainder of this dissertation describes the use of a heterologous expression
system to focus on the intracellular Golgi localization of Kv1.3 as a potential mechanism
for channel regulation. This research quantitatively identifies the inverse relationship
between Kv1.3 Golgi localization and the amount of channel in the plasma membrane.
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The extreme C-terminal region of Kv1.3 contains a PDZ-binding motif which is known
to participate in protein-protein interactions that aid channel localization to various
cellular compartments (Kim et al., 1995). We show that removal of this PDZ-binding
motif decreases Kv1.3 Golgi localization and increases Kv1.3 ionic current, suggesting
that Golgi retention may be a mechanism for regulating the amount of functional channel
in the plasma membrane. Collectively, the work in this dissertation identifies Kv1.3 as an
important determinant of sympathetic neuronal function and provides insight into the
regulatory checkpoints of the channel that may serve as targets for Kv1.3-mediated drug
therapy in human disease.
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Abstract
Kv1.3 channels are known to modulate many aspects of neuronal function. We
tested the hypothesis that Kv1.3 modulates the function of postganglionic sympathetic
neurons. RT PCR, immunoblot and immunohistochemical analyses indicated that Kv1.3
channels were expressed in these neurons. Immunohistochemical analyses indicated that
Kv1.3 protein was localized to neuronal cell bodies, processes, and nerve fibers at
sympathetic neurovascular junctions. Margatoxin (MgTX), a specific inhibitor of Kv1.3,
was used to assess the function of the channel. Electrophysiological analyses indicated
that MgTX significantly reduced outward currents (p < 0.05; n = 18 (control) and 15
(MgTX)), depolarized resting membrane potential, and decreased the latency to action
potential firing (p < 0.05; n = 11 (control) and 13 (MgTX)). The primary physiological
input to postganglionic sympathetic neurons is acetylcholine, which activates nicotinic
and muscarinic acetylcholine receptors.

MgTX modulated nicotinic acetylcholine

receptor agonist-induced norepinephrine release (p < 0.05; n ≥ 6), and MgTX-sensitive
current was suppressed upon activation of muscarinic acetylcholine receptors with
bethanechol (p < 0.05; n = 12). These data indicate that Kv1.3 affects the function of
postganglionic sympathetic neurons, which suggests that Kv1.3 influences sympathetic
control of cardiovascular function. Our data also indicate that modulation of Kv1.3 is
likely to affect sympathetic control of cardiovascular function.
Introduction
The sympathetic nervous system is a major determinant of cardiovascular
function and is implicated in cardiovascular disease (Carlson et al., 2000; Dakak et al.,
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1995; Dhital et al., 1988; Esler et al., 2006; Fingerle et al., 1991; Guyenet, 2006; Karoon
et al., 1995; Kolo et al., 2004; Lee et al., 1987; Luo et al., 2003; Sauzeau et al., 2006;
Schrier and Abraham, 1999).

Many effects of the sympathetic nervous system on

cardiovascular function are mediated via neurotransmitters released from postganglionic
sympathetic neurons innervating blood vessels.

The mechanisms governing

neurotransmitter release at sympathetic neurovascular junctions are not completely
understood.
Kv1 family potassium channels consist of eight genes encoding distinct alpha
subunit proteins, Kv1.1 through Kv1.8, and are expressed throughout the nervous system
(Dixon and McKinnon, 1996; Guan et al., 2006; Gutman et al., 2003; Hatton et al., 2001;
Ichikawa and Sugimoto, 2003; Malin and Nerbonne, 2001; Nashmi et al., 2000;
Popratiloff et al., 2003; Szulczyk et al., 2006; Tsaur et al., 1992; Veh et al., 1995; Wang
et al., 1994).

Functional Kv1 channels are formed when four Kv1 alpha subunits

assemble as homotetramers or as heterotetramers with other members of the Kv1 family.
These channels affect a range of neuronal functions (Dodson et al., 2002; Fadool et al.,
2004; Glazebrook et al., 2002; Haghdoust et al., 2006; Kupper et al., 2002; McFarlane
and Pollock, 2000; McKay et al., 2005; Mo et al., 2002), including spike frequency
adaptation (McKay et al., 2005; Mo et al., 2002) and the regulation of cellular excitability
in response to synaptic input (Glazebrook et al., 2002). Postganglionic sympathetic
neurons express Kv1 channels (Dixon and McKinnon, 1996; Malin and Nerbonne, 2001;
Szulczyk et al., 2006) and inhibition of these channels has been reported to modulate
neurotransmitter release from these neurons (Ikushima et al., 1981; Jackson et al., 2001;
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Uhrenholt and Nedergaard, 2003). However, the mechanisms involved in Kv1 channel
modulation of neurotransmitter release in sympathetic neurons are largely unexplored.
Kv1.3 channels play a key role in a wide range of physiological phenomena.
Kv1.3 is required for the activation of T-lymphocytes, and is thus a determinant of
immune function (Beeton et al., 2006). Inhibition of Kv1.3 facilitates translocation of the
insulin sensitive glucose transporter, GLUT4, to the plasma membrane of adipocytes (Li
et al., 2006) and skeletal muscle (Xu et al., 2004), and is thus a determinant of glucose
homeostasis. Kv1.3 has also been shown to contribute to body weight regulation and
energy homeostasis, processes that are regulated by the sympathetic nervous system (Xu
et al., 2003). In neurons, Kv1.3 has been reported to modulate action potential firing (8,
26).
Here we evaluate the role of Kv1.3 in postganglionic sympathetic neuron
function. We demonstrate that this channel is present and functional in postganglionic
sympathetic neurons. Kv1.3 was detected throughout the neurons, in both soma and
processes.

It contributed to outward currents recorded from the soma and was a

determinant of resting membrane potential and neurotransmitter release. These studies
show that Kv1.3 channels are important determinants of postganglionic sympathetic
neuronal function and have important implications for understanding the effects of the
sympathetic nervous system on cardiovascular function.
Materials and Methods
Animals. The use of animals in the present studies was in accordance with the National
Institutes of Health guidelines for the humane care and use of animals in research and
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was approved by the Institutional Animal Care and Use Committee of the University of
Vermont.

Neonatal Sprague Dawley rats were used to obtain superior cervical

sympathetic ganglia (SCG). Adult postpartum female Sprague Dawley rats were used to
obtain SCG and tail arteries. The postpartum females used in the present studies were the
mothers of the neonatal rats and were used to minimize the number of animals.
Neuronal Culture. Postganglionic sympathetic neurons were isolated from the SCG of
neonatal (3 - 4 days) Sprague Dawley rats (males and females). Ganglia were dissociated
for 10 minutes at 37°C in a collagenase/hyaluronidase solution (10 mg/ml bovine serum
albumin, 4 mg/ml collagenase, 1 mg/ml hyaluronidase in Dulbecco’s phosphate buffered
saline) and then for 10 minutes in trypsin (3 mg/ml added to trypsin-EDTA). Dissociated
cells were resuspended in neuronal growth medium (DMEM/F12 supplemented with
10% NuSerum (BD Biosciences), 5% fetal bovine serum (Invitrogen) and
penicillin/streptomycin), supplemented with NGF (BD Biosciences; 50 ng/ml), and
applied to collagen-coated tissue culture dishes.

The cells were allowed to attach

overnight in a humidified 5% CO2 environment maintained at 37°C. Non-neuronal cells
were then growth arrested with mitomycin C (Sigma; 10 μg/ml for 1 hour). These
cultures of neurons will be subsequently referred to as dissociated neurons.
RT-PCR. RNA was isolated with RNAeasy mini kits from Qiagen. Equal amounts of
RNA were reverse transcribed (RetroScript, Ambion) and equal amounts of cDNA
amplified (Amplitaq Gold, Applied Biosystems).

PCR primers and annealing

temperatures are indicated in Table 1. PCR products were electrophoresed on 1.2%
agarose gels containing ethidium bromide and visualized with UV light.

All PCR

reactions included (–) RT and (–) template controls. Amplified PCR products were
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sequenced by the University of Vermont DNA facility to confirm the identity of the
DNA.
Western Analyses. Tissues and cells were lysed and homogenized in enhanced RIPA
buffer (50 mM Tris, 150 mM NaCl, 10 mM EDTA 0.25% deoxycholate 1% NP40, 10%
glycerol, 1% protease inhibitor cocktail (Sigma), 1 mM dithiothreitol, 0.1% sodium
dodecyl sulfate; pH 8.0). Samples were diluted with equal volumes of electrophoresis
running buffer, boiled for 5 minutes and electrophoresed on 4 – 20% gradient acrylamide
gels. Samples were then transferred to nitrocellulose membranes. The membranes were
blocked with PBS containing 0.05% Tween and 3% nonfat dry milk (30 minutes at room
temperature) and then incubated overnight at 4 C in PBS-Tween containing 3% nonfat
dry milk, and primary antibody (0.2 μg/ml anti-Kv1.3 (NeuroMab) and 1 μg/ml antiTyrosine Hydroxylase (TH; Sigma)). The Kv1.3 mouse monoclonal antibody, IgG2a
isotype, was raised against synthetic peptide amino acids 485-506 of rat Kv1.3 (clone
L23/27; Lot # 413-5RR-07). The TH mouse monoclonal antibody recognizes the Nterminal epitope between amino acids 40-152 of rodent and human TH (Lot #
016K4857). Unbound primary antibody was removed with three 5 minute washes (PBSTween). The membranes were then incubated in PBS-Tween containing 3% nonfat dry
milk and horseradish peroxidase-conjugated secondary antibodies (1:3000; Biorad) for
one hour at room temperature. The horseradish peroxidase was detected with enhanced
chemiluminescence (Pierce) and documented on autoradiographic film.
Immunofluorescence. Cultures of postganglionic sympathetic neurons were rinsed in
PBS and fixed in 4% formaldehyde in PBS for 12 min. SCG and tail arteries were
dissected from adult postpartum female rats and fixed in 4% formaldehyde in PBS for 1
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or 2 hours, respectively. Ganglia were immersed in 30% sucrose in PBS overnight and
frozen in Tissue-Tek O.C.T. compound (Electron Microscopy Sciences) and sliced to a
thickness of 30 µm at -20°C. SCG sections and dissociated neurons were permeabilized
with 0.2% Triton X-100 in PBS for 5 min and subsequently rinsed in PBS. Tail arteries
were permeabilized with acetone for 5 min and rinsed in PBS. Cultures, SCG sections,
and whole mount tail arteries were blocked for 1 hour in 3% goat serum, 0.1% fish skin
gelatin in PBS. A rabbit polyclonal TH antibody (0.16 μg/ml; Chemicon), raised against
denatured rat TH (Lot # 0512016843), was used to identify neurons. A rabbit polyclonal
GM130 antibody (0.7 μg/mL; Calbiochem), raised against recombinant protein
containing amino acids 371-990 of human GM130 (Lot # D00004465), was used to
identify the Golgi apparatus.

The same monoclonal Kv1.3 antibody (0.84 μg/mL;

NeuroMab) used for western analyses was also used to identify Kv1.3. Cells were
incubated in primary antibodies overnight at 4°C, followed by three 5 min washes in
PBS. Alexa Fluor Goat anti-mouse (cultures 568 nm; SCG and tail arteries 647 nm) and
goat anti-rabbit (488 nm) secondary antibodies (4 μg/ml; Invitrogen) were applied for 1
hour at room temperature and all samples were mounted using ProLong Gold antifade
reagent (Invitrogen). All images were taken using the Olympus IX70 microscope and
DeltaVision Restoration Imaging System (Applied Precision, LLC) and background
subtracted with an IgG2a isotype control (R&D Systems).
Neuronal transfection. Neurons were transfected using the Helios Gene Gun (BioRad)
with pEGFP or pEGFP-Kv1.3. pEGFP coated bullets were a generous gift from Dr.
Victor May (University of Vermont, Department of Anatomy and Neurobiology).
pEGFP-C1-Kv1.3 was a generous gift from Dr. Jürgen Kupper ((Kupper, 1998); Max
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Planck Institute of Biochemistry, Martinsried, Germany). Cells were studied 48 hrs after
transfection.
Electrophysiology. Electrophysiological recordings were performed at room temperature,
utilizing the whole cell patch clamp technique. Data acquisition and analysis were
obtained using the Axopatch 200B (Axon Instruments) patch clamp amplifier and
pCLAMP 9.2 (Axon Instruments) software. Electrodes were pulled in two stages from
thin wall filament glass capillary tubing (Warner Instruments) and fire polished to a
resistance ranging from 1 – 2 MΩ. Voltage clamp recording solutions were as follows
(in mM): external (bath) solution 100 NaCl, 5.4 KCl, 1.8 CaCl2. 0.8 MgCl2, 23 glucose,
5 Na Hepes, 0.001 tetrodotoxin (TTX), 10 tetraethylammonium (TEA), pH 7.4; internal
(pipette) solution: 120 KCl, 3.69 CaCl2, 0.094 MgCl2, 5 BAPTA, 5 EDTA, 5 Na HEPES,
5 glucose, pH 7.2. Pharmacological agents were applied at the following concentrations:
1 nM Margatoxin (MgTX; Alomone), 100 nM α-Dendrotoxin (DTX; Research
Biochemicals International) and 100 μM Bethanechol (BeCh; Sigma). Cells were held at
-60 mV, followed by a 20 ms hyperpolarization to -90 mV, and stepped from -70 mV to
+50 mV in 10 mV increments. Leak currents (P/8) were subtracted from all traces.
Averaged MgTX traces were subtracted from averaged control traces to obtain the
resolved Kv1.3 current. Current clamp recording solutions were the same as listed above,
except that TTX and TEA were omitted. Resting membrane potential was monitored for
100 ms, followed by 400ms current injections of the following magnitudes (in pA): -500,
500, 1000, 1500, 2000, and 2500. Latency to action potential firing was defined as the
time between the start of the current injection and the peak of the action potential. Action

60

potential width was measured at half the action potential amplitude as previously
described (Guan et al., 2007).
Norepinephrine release.

Norepinephrine (NE) release was assessed using tritiated

norepinephrine purchased from Amersham. These assays were performed using HEPESbuffered Krebs solution [122 mM NaCl, 3 mM KCl, 0.4 mM MgSO4 · H2O, 1.2 mM
KH2PO4, 10 mM Glucose, 20 mM HEPES, 1.3 mM CaCl2 · 2H2O, 1 mM Ascorbic Acid,
10 μM Pargyline, pH 7.4]. Cells were preincubated at 37ºC with 100 nM tritiated
norepinephrine for 30 minutes.

The cells were then washed (6 x 5 minutes) and

stimulated with a nicotinic agonist, dimethylphenylpiperazinium (DMPP; 30 μM;
Sigma). The remaining cell associated NE was then extracted with acidified ethanol. NE
in all samples was collected and analyzed using a Beckman LS6000IC Liquid
Scintillation Counter (Beckman Instruments). Stimulated release was calculated using
the following equation: (stimulated cpm – background cpm) / (total cpm available for
release).
Statistics. Data are presented as means ± standard errors. Unpaired Student’s t-tests
assuming unequal variances were used to determine statistical differences. Differences
were considered significant if p ≤ 0.05.
Results
To begin to assess the function of Kv1.3 channels in postganglionic sympathetic
neurons, we first characterized the expression and subcellular localization of these
channels. Kv1.3 mRNA and protein were detected in dissociated neurons (d), and in
intact neonatal (n) and adult (a) ganglia (figure 1A). Potassium channel effects on
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neuronal physiology are strongly influenced by their location within the cell, therefore we
used immunofluoresence microscopy to examine the subcellular localization of Kv1.3
protein (figure 1B and 1C). Neurons were identified with antibodies directed against
tyrosine hydroxylase. In dissociated neurons and freshly isolated tissues, Kv1.3 was
detected in both the soma and processes. In the soma, Kv1.3 exhibited a striking pattern
of localization to a discrete intracellular compartment that overlaps with the GM130
Golgi apparatus marker in dissociated neurons (figure 2).

All dissociated neurons

observed expressed Kv1.3 and exhibited this intracellular localization pattern.
Because the striking intracellular localization detected with anti-Kv1.3 is not
typical for a membrane-associated ion channel, we used GFP-Kv1.3 as an alternate
approach to assess the subcellular localization of Kv1.3.

The distribution of

overexpressed GFP-Kv1.3 overlapped with that detected by Kv1.3 immunofluorescence
(figure 3). The distribution of overexpressed GFP differed considerably from GFP-Kv1.3
and Kv1.3 immunofluorescence (figure 3). Intracellular compartmentalization of Kv1.3
was also observed in sympathetic neurons in adult ganglia (figure 1C).
We next determined the function of Kv1.3 in postganglionic sympathetic neurons.
We used whole cell patch clamp electrophysiology in the absence and presence of
margatoxin (MgTX), a specific inhibitor of Kv1.3 (Garcia-Calvo et al., 1993). To resolve
Kv1.3 currents, all measurements were recorded in the presence of 1 μM TTX and 10
mM TEA to block currents generated by sodium and non-Kv1 family potassium
channels. Steady state currents measured in untransfected dissociated postganglionic
sympathetic neurons were significantly suppressed by MgTX (1 nM; n = 15) relative to
control (n = 18; p < 0.02) (figure 4A). This indicates that endogenous Kv1.3 channels
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contribute to outward current recorded from the soma of postganglionic sympathetic
neurons.

To confirm that MgTX inhibited Kv1.3, steady state currents were also

measured in dissociated postganglionic sympathetic neurons expressing GFP-Kv1.3.
Outward currents in transfected cells were markedly increased, indicating that GFPKv1.3 was functional in these cells. MgTX (1 nM) elicited an 86% decrease in this
current (figure 4B; n = 3; p < 0.002). Activation curves were generated from tail currents
and fit to a Boltzmann function.
endogenous and GFP-Kv1.3.

These curves are shown in figure 4C for both

Half activation voltages (V1/2) determined from these

curves were -22.8 mV for endogenous MgTX-sensitive current and -27.2 mV for GFPKv1.3, values consistent with previously published reports (Vicente et al., 2008a).
At concentrations higher than that used in the present studies, MgTX has been
reported to inhibit Kv1.6 (Garcia-Calvo et al., 1993). To evaluate the contribution of
Kv1.6 to the MgTX-sensitive current measured in figure 4A, we measured steady state
ionic currents in dissociated postganglionic sympathetic neurons in the presence of αdendrotoxin (DTX), an inhibitor of Kv1.6, as well as Kv1.1 and Kv1.2 channels (Harvey,
2001). DTX (100 nM) had no effect on steady state currents in these cells (p > 0.05; n ≥
10) (figure 4D).

Steady state outward currents recorded in HEK 293 cells stably

transfected with Kv1.2 were significantly suppressed in the presence of DTX (100 nM; n
= 4; p < 0.05; data not shown), confirming the effectiveness of this inhibitor. These
findings support our conclusion that the MgTX-sensitive current shown in figure 4A is
attributable to Kv1.3.
Current clamp electrophysiology was used to elucidate the physiological role of
Kv1.3 current in dissociated postganglionic sympathetic neurons. Resting membrane
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potential measured in the presence of MgTX (-45.7 mV ± 2.1; n = 13) was significantly
depolarized relative to control (-51.9 mV ± 2.3; n = 11; p < 0.05) (figure 5B). In
addition, the latency to action potential firing in the presence of MgTX (26.9 ms ± 1.3; n
= 13) was significantly less than control (39.9 ms ± 5.4; n = 11; p < 0.05) (figure 5C).
MgTX did not alter the width of the action potential measured at half peak amplitude
(figure 5D).
Acetylcholine (Ach) is the preganglionic neurotransmitter for postganglionic
sympathetic neurons. ACh activates both nicotinic (nAChR) and muscarinic (mAChR)
acetylcholine receptors in these neurons (Lechner et al., 2003). Activation of mAChRs is
known to suppress ionic current of Kv1 family channels (Huang et al., 1993). We found
that bethanechol (BeCh; 100 μM), a mAChR selective agonist, significantly decreased
outward current measured in dissociated neonatal sympathetic neurons (figure 6A; n =
12; p < 0.05). Inhibition of Kv1.3 with MgTX abrogated the effect of BeCh, suggesting
that activation of mAChRs suppresses Kv1.3 current in these cells (figure 6B; n = 12; p >
0.05). In HEK cells lacking muscarinic receptors, but transfected with GFP-Kv1.3, BeCh
did not decrease Kv1.3 current at any voltage (data not shown; n = 8; p > 0.05). These
data indicate that BeCh did not directly affect Kv1.3.
The ultimate function of postganglionic neurons is to release neurotransmitter,
thereby affecting the function of sympathetic targets. Therefore, we assessed the effect of
Kv1.3 on NE release from these neurons. Acetylcholine is the physiological stimulus for
neurotransmitter release from these neurons.
activation of nAChRs.

This effect is primarily mediated by

Therefore, we used DMPP, a nAChR selective agonist to

stimulate neurotransmitter release. Application of 30 μM DMPP stimulated NE release
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from dissociated neonatal neurons. Inhibition of Kv1.3 with MgTX (1 nM) increased NE
release from these cells (figure 7; n = 6; p < 0.05).
Discussion
The present studies provide novel evidence that Kv1.3 determines the function of
postganglionic sympathetic neurons. Expression analyses indicated that Kv1.3 is present
in these neurons. Electrophysiological analyses indicated that this channel contributes to
outward current and the maintenance of resting membrane potential. Pharmacological
inhibition of Kv1.3 increased neurotransmitter release. In addition, we demonstrated that
this channel was modulated by preganglionic mechanisms. Postganglionic sympathetic
neurons are important determinants of cardiovascular function.

Thus, our studies

strongly suggest that Kv1.3 channels and their modulation are important determinants of
sympathetic control of cardiovascular function.
The present studies are the first to demonstrate that Kv1.3 protein is expressed in
postganglionic sympathetic neurons. RT-PCR, immunoblot, and immunohistochemical
analyses indicate that Kv1.3 was in the soma. Kv1.3 was concentrated in an intracellular
compartment (figures 1, 2 and 3). Similar localization of Kv1.3 has been reported in
other cells and tissues (Guan et al., 2006; O'Connell and Tamkun, 2005). Figure 2
indicates that this compartment is the Golgi apparatus. Kv1.3 was also detected in the
processes of dissociated neurons as well as in nerve fibers on the adventitial surface of
freshly isolated tail arteries. These data suggest that Kv1.3 channels are likely to affect
the function of postganglionic sympathetic neurons in general and in particular, to affect
sympathetic control of vascular function.
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Functional analyses of Kv1.3 indicate that this channel is a determinant of the
electrophysiological properties of postganglionic sympathetic neurons. MgTX, a specific
inhibitor of Kv1.3 (Garcia-Calvo et al., 1993), decreased outward currents measured in
these cells (figure 4A). In contrast, DTX, an inhibitor of Kv1.6, Kv1.1 and Kv1.2
(Harvey, 2001), had no effect on outward currents in these neurons (figure 4D). This
indicates that MgTX is specific for Kv1.3, and that Kv1.1, Kv1.2 and Kv1.6 do not
significantly contribute to the outward current measured in these neurons.

Action

potential analyses presented in figure 5 indicate that Kv1.3 contributes to the
maintenance of resting membrane potential. MgTX significantly decreased the latency to
action potential firing, consistent with the depolarization of resting membrane potential.
This is the first demonstration that Kv1.3 affects the function of postganglionic
sympathetic neurons.
Our immunohistochemical and functional analyses indicate that Kv1.3 is localized
to both the plasma membrane and Golgi apparatus in postganglionic sympathetic
neurons.

We detected Kv1.3 current in non-transfected cells indicating surface

localization of the channel (figure 4A). In non-transfected cells, surface expression of
Kv1.3 was below the level of detection of our immunohistochemical analyses (figure
1B). In neurons that were transfected with GFP-Kv1.3, surface expression was easily
detectable (figure 3).

In both non-transfected and transfected neurons, our

immunohistochemical analyses detected a fraction of Kv1.3 localized to the Golgi
apparatus (figures 2, 3). Cellular localization is an important determinant of ion channel
function (Lai and Jan, 2006). Our data thus suggest that Golgi localization or retention
may be a determinant of surface expression and function of Kv1.3.
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The primary preganglionic input to these neurons is ACh. It is well known that
activation of mAChRs modulates KCNQ potassium channels in postganglionic
sympathetic neurons and that this modulation affects neurotransmitter release (Lechner et
al., 2003). In addition, previous studies indicate that activation of mAChRs modulates
the function of Kv1 channels (Huang et al., 1993). We show that activation of mAChRs
suppresses Kv1.3 current in postganglionic sympathetic neurons (figure 6). This data
demonstrates a novel effect of mAChR activation, a novel mechanism of Kv1.3
modulation, and suggests a new mechanism by which mAChR activation modulates
membrane excitability.
In addition to activating mAChRs, release of ACh from preganglionic neurons
activates nAChRs. Nicotinic AChR activation is the primary mechanism for generating
action potentials and eliciting neurotransmitter release from postganglionic sympathetic
neurons. We assessed the effects of Kv1.3 on nicotinic receptor-induced NE release. Our
data indicate that inhibition of Kv1.3 enhanced NE release (figure 7). This suggests that
Kv1.3 is acting to suppress membrane excitability and thereby inhibit neurotransmitter
release. These findings are consistent with previous reports demonstrating that inhibition
of Kv1 family channels enhances neurotransmitter release. The work of Jackson et al.
(Jackson et al., 2001) and Uhrenholt et al. (Uhrenholt and Nedergaard, 2003) indicate that
inhibition of Kv1 channels enhances NE release at sympathetic neurovascular junctions.
Our findings that Kv1.3 channels are present in processes innervating arteries and that
MgTX enhances NE release, suggest that these channels play a role in modulating
sympathetic neurovascular transmission.
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Our data clearly indicate that Kv1.3 channels influence the function of
postganglionic sympathetic neurons derived from the SCG of the rat, a representative
paravertebral sympathetic ganglion. The postganglionic sympathetic neurons in this
ganglion innervate many targets including blood vessels (Li and Horn, 2006). Kv1.3 was
expressed in all of the neurons that were studied, suggesting that Kv1.3 affects
sympathetic regulation of all SCG targets. The studies of Dixon and McKinnon (Dixon
and McKinnon, 1996) indicate that Kv1.3 is also expressed in prevertebral ganglia
suggesting a general role for Kv1.3 in postganglionic sympathetic neuronal function. Our
finding that Kv1.3 is expressed in the fibers innervating the tail artery (figure 1C)
strongly suggests that Kv1.3 affects neurotransmitter release at sympathetic
neurovascular junctions. This would suggest that Kv1.3 is a determinant of sympathetic
control of blood flow and blood pressure.
Perspectives and Significance
Compelling evidence suggests that the sympathetic nervous system contributes to
the development and/or maintenance of cardiovascular disease (Carlson et al., 2000;
Dakak et al., 1995; Dhital et al., 1988; Esler et al., 2006; Fingerle et al., 1991; Guyenet,
2006; Karoon et al., 1995; Kolo et al., 2004; Lee et al., 1987; Luo et al., 2003; Sauzeau et
al., 2006; Schrier and Abraham, 1999; Small et al., 2002). Sympathetic activity is
increased in hypertensive animals and humans, and sympathoinhibition decreases blood
pressure (Dhital et al., 1988; Guyenet, 2006; Karoon et al., 1995; Kolo et al., 2004; Lee et
al., 1987; Sauzeau et al., 2006). Hypertension is also a complication of diabetes and
obesity.

Elevated sympathetic activity is thought to contribute to these forms of
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hypertension (Carlson et al., 2000; Esler et al., 2006). Sympathetic activity is increased
in many patients with heart failure, and this increased activity contributes to the
pathology of this disease (Schrier and Abraham, 1999; Small et al., 2002). The present
studies suggest that Kv1.3 channels in postganglionic sympathetic neurons are
determinants of sympathetic activity and therefore are potential therapeutic targets for the
prevention and treatment of cardiovascular disease.
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Figure Legends

Figure 1: Kv1.3 channels are present in postganglionic sympathetic neurons.

A)

RT-PCR (top; n = 2) shows expression of mRNA for Kv1.3 in neonatal dissociated
neurons (d), neonatal sympathetic superior cervical ganglia (SCG) (n) and adult
sympathetic SCG (a). PCR reactions included minus reverse transcriptase (–RT) and
minus template (-T) controls.

Kv1.3 and tyrosine hydroxylase (TH) immunoblots

(bottom; n = 2) show corresponding protein expression. TH was used as a marker of
postganglionic sympathetic neurons.

Approximate molecular weight is noted with

arrows. B) Immunolocalization of Kv1.3 (top) and TH (bottom) in the soma (left) and
processes (right) of dissociated postgangalionic sympathetic neurons in vitro (n = 2).
Scale bar = 10μm. C) Immunolocalization of Kv1.3 (top) and TH (bottom) in neuronal
soma of intact adult sympathetic SCG (left) and of processes innervating adult rat tail
arteries (right) (n = 2). SCG scale bar = 10μm; tail artery scale bar = 30μm.

Figure 2: Kv1.3 overlaps with a marker for the Golgi Apparatus in postganglionic
sympathetic neurons. Immunoreactivity of endogenous Kv1.3 (red) overlaps with the
Golgi marker, GM130 (green), in the soma of dissociated postganglionic sympathetic
neurons. The far right panel depicts the overlap between these two antibodies (merge; n
= 3). Scale bar = 10μm.
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Figure 3:

Localization of transfected GFP-Kv1.3 versus endogenous Kv1.3 in

postganglionic sympathetic neurons. GFP-Kv1.3 (top left) and immunoreactive Kv1.3
(top right) overlap in postganglionic sympathetic neurons (n = 3). Neurons transfected
with GFP only (bottom left) do not overlap with immunoreactive Kv1.3 (bottom right) (n
= 3). Scale bar = 10μm.

Figure 4: Voltage clamp analyses of Kv1.3 in postganglionic sympathetic neurons.
A) Ionic current measured in untransfected dissociated sympathetic neurons in the
absence (control; n = 18) and presence of 1 nM Margatoxin (MgTX; n = 15). Current
traces for each condition represent the average of unpaired measurements made in
multiple cells. * indicates MgTX was significantly different from control (p ≤ 0.05;
unpaired t-test).

Resolved Kv1.3 current was obtained by subtracting MgTX from

control. B) Ionic current measured in dissociated sympathetic neurons transfected with
GFP-Kv1.3 in the absence (control; n = 3) and presence of 1 nM MgTX (n = 3). Current
traces for each condition represent the average of unpaired measurements made in
multiple cells. * indicates MgTX was significantly different from control (p ≤ 0.02;
unpaired t-test). Resolved GFP-Kv1.3 current was obtained by subtracting MgTX from
control. C) Activation curves were plotted from the tail current of endogenous Kv1.3 and
GFP-Kv1.3 and fit to a Boltzmann equation. D) Ionic current measured in dissociated
sympathetic neurons in the absence (control; n = 10) and presence of 100 nM DTX (n =
18; p > 0.05).
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Figure 5: Current clamp analyses of Kv1.3 in postganglionic sympathetic neurons.
A) Representative traces of phasic action potentials recorded from the soma of
dissociated postganglionic sympathetic neurons in the absence (control; black line) and
presence (MgTX; red line) of 1 nM MgTX. B) The resting membrane potential, C) the
latency to action potential firing, and D) the action potential width as measured at half the
action potential amplitude in the absence (open bars; n = 11) and presence (closed bars; n
= 13) of 1 nM MgTX. * indicates MgTX was significantly different from control (p <
0.05; unpaired t-test).

Figure 6: Preganglionic modulation of Kv1.3 in postganglionic sympathetic neurons.
A) Steady state current-voltage curves for postganglionic sympathetic neurons in the
absence (open symbols) and presence (closed symbols) of muscarinic acetylcholine
receptor activation using 100μM Bethanechol (BeCh). B) Steady state current-voltage
curves for postganglionic sympathetic neurons treated with 1nM MgTX in the absence
(open symbols) and presence (closed symbols) of 100μM BeCh. * indicates BeCh was
significantly different from control (n = 12; p < 0.05; unpaired t-test).

Figure 7: Kv1.3 affects norepinephrine release from postganglionic sympathetic
neurons. Tritiated norepinephrine release from neuronal cultures in response to a 30 μM
dimethylphenylpiperazinium (DMPP) treatment in the absence (open bar) and presence
(closed bar) of MgTX (1 nM, 10 min). * indicates MgTX was significantly different
from control (p < 0.05; unpaired t-test).
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Tables

Table 1: Forward and reverse PCR primer sequences

mRNA

Primer Sequences

Annealing Temp
(°C)

Kv1.3

5’-GTA CTT CGA CCC GCT CCG CAA TGA -3’
5’-GGG CAA GCA AAG AAT CGC ACC AG -3’
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Figure 1: Kv1.3 channels are present in postganglionic sympathetic neurons.
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Figure 2: Kv1.3 overlaps with a marker for the Golgi Apparatus in postganglionic
sympathetic neurons.
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Figure 3: Localization of transfected GFP-Kv1.3 versus endogenous Kv1.3 in
postganglionic sympathetic neurons.
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Figure 4A: Voltage clamp analyses of Kv1.3 in postganglionic sympathetic neurons.
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Figure 4B: Voltage clamp analysis of Kv1.3 in postganglionic sympathetic neurons.
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Figure 4C: Voltage clamp analysis of Kv1.3 in postganglionic sympathetic neurons.
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Figure 4D: Voltage clamp analysis of Kv1.3 in postganglionic sympathetic neurons.
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Figure 5: Current clamp analyses of Kv1.3 in postganglionic sympathetic neurons.
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Figure 6: Preganglionic modulation of Kv1.3 in postganglionic sympathetic neurons.
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Figure 7: Kv1.3 affects norepinephrine release from postganglionic sympathetic
neurons.
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Abstract
The voltage-gated potassium channel, Kv1.3, plays an important role in regulating
membrane excitability in diverse cell types ranging from neurons to T-lymphocytes.
Subcellular localization of ion channels is a key mechanism for determining their
function. We observed that Kv1.3 is localized primarily to the Golgi apparatus and the
plasma membrane. The degree of Kv1.3 Golgi localization is inversely correlated with
the amount of channel at the plasma membrane. The amplitude of Kv1.3 ionic current
measured in cells with low Kv1.3 Golgi localization was significantly greater than the
current measured in cells with high Kv1.3 Golgi localization. We therefore hypothesized
that Golgi localization is a determinant of Kv1.3 function. One mechanism for localizing
ion channels to the Golgi apparatus involves the Class I PDZ-binding motif (X-S/T-X-Φ).
The C-terminal region of Kv1.3 contains a canonical PDZ-binding motif. Deletion of this
motif decreases Kv1.3 Golgi localization and increases channel localization at the cell
surface. Deletion of this region also increased the amplitude of Kv1.3 ionic current. We
propose that Golgi retention serves as a checkpoint for regulating the surface expression
and function of Kv1.3.

Introduction
The Kv1.3 voltage-gated potassium channel is a key determinant of function in
many cell types. Kv1.3 plays a central role in regulating resting membrane potential,
Ca2+ signaling cascades, and antigen-dependent activation and proliferation in Tlymphocytes, key mediators of autoimmune disease (Beeton et al., 2006; Panyi, 2005;
Panyi et al., 2004b). In adipocytes and skeletal muscle, Kv1.3 influences glucose
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transport, (Desir, 2005; Li et al., 2006; Li et al., 2007) and studies in Kv1.3 deficient
mice indicate that the channel is a determinant of body weight and energy homeostasis
(Fadool et al., 2004; Tucker et al., 2008; Xu et al., 2003). Several studies also
demonstrate that Kv1.3 influences neuronal resting membrane potential, action potential
characteristics, neurotransmission, and synaptic refinement (Biju et al., 2008; Doczi et
al., 2008; Kupper et al., 2002), further underscoring the physiological significance of
Kv1.3 in multiple cellular processes.
The localization of ion channels to distinct cellular compartments can influence
cellular function. For example, activity-regulated local translation of Kv1.1 in
hippocampal dendrites contributes to channel surface expression, potentially modulating
local cellular excitability (Raab-Graham et al., 2006). Modulated endocytosis of Kv1.2
facilitates both positive and negative plasma membrane trafficking of the channel in
HEK293 cells, in turn altering Kv1.2 activity at the cell surface (Connors et al., 2008;
Nesti et al., 2004). Plasma membrane expression of the Cystic Fibrosis transmembrane
conductance regulator (CFTR), a chloride channel that is enriched in the Golgi apparatus,
is potentially regulated via channel transit from the Golgi to the plasma membrane
(Cheng et al., 2002; Cheng et al., 2004; Guggino, 2004; Moyer et al., 2000). Previous
work from our laboratory indicates that in postganglionic sympathetic neurons, Kv1.3
also exhibits localization to the Golgi apparatus (Doczi et al., 2008). In this study, we
propose that Kv1.3 Golgi localization is a mechanism for regulating channel activity at
the cell surface, in turn influencing cellular function.
One mechanism for localizing ion channels to the Golgi apparatus involves the
Class I PDZ-binding motif (X-S/T-X-Φ). This motif is found at the extreme carboxy93

terminus of proteins and serves as a ligand for the binding of postsynaptic density95/discs-large/zona-occludens-1 (PDZ) domain containing proteins (Hung and Sheng,
2002). CFTR channels contain a PDZ-binding motif that associates with the Golgi
localized PDZ domain protein, CFTR associated ligand (CAL), potentially tethering the
channel to this subcellular compartment (Cheng et al., 2002; Cheng et al., 2004; Guggino,
2004; Moyer et al., 2000). The ClC-3B chloride channel is a PDZ-binding isoform of the
ClC family that also exhibits intracellular localization to the Golgi apparatus (Gentzsch et
al., 2003). Similarly, ClC-3B transit from the Golgi to the plasma membrane is dependent
upon interactions with PDZ domain proteins. Potassium channels also contain PDZbinding motifs and interactions of these motifs with PDZ proteins play a role in channel
localization. For example, the PDZ domain containing scaffold protein, Postsynaptic
density-93 (PSD-93), induces clustering of Kv1 channels to the axon initial segment in
neurons (Ogawa et al., 2008). Altering associations with the C-terminal PDZ-binding
motif of potassium ion channels can lead to significant changes in channel function
(Cheng et al., 2002; Cheng et al., 2004; Guggino, 2004; Mery et al., 2002; SwiateckaUrban et al., 2002). Coexpression of an inward rectifier potassium channel, Kir2.3, with
the synaptic adaptor protein, post synaptic density 95 (PSD-95), functionally suppresses
the activity of the channel by reducing its single channel conductance (Nehring et al.,
2000).
The C-terminus of Kv1.3 contains a PDZ-binding motif which is known to
associate with PDZ domain containing proteins (Kim et al., 1995). A recent study
demonstrates that PSD-95 clusters Kv1.3 channels into specific membrane microdomains
(Marks and Fadool, 2007). In addition, PSD-95 also suppresses the current magnitude of
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Kv1.3 channels via an activity-dependent mechanism (Marks and Fadool, 2007). Thus,
PDZ interactions play an integral role in the localization and function of Kv1.3.
In the present study, we test the hypothesis that the PDZ-binding motif of Kv1.3
plays a role in regulating the intracellular Golgi localization and electrophysiological
function of the channel. We show that Golgi localization of WT Kv1.3 is inversely
correlated with surface expression of the channel. Disrupting the C-terminal PDZ-binding
motif of Kv1.3 significantly decreased Golgi localization of the channel. In addition, this
mutation also caused an increase in Kv1.3 ionic current. These findings suggest that the
PDZ-binding motif dependent localization of Kv1.3 to the Golgi apparatus is a
mechanism for regulating the level of functional channel at the cell surface.

Materials and Methods
Cell Culture and Transient Transfection- Clonal human embryonic kidney 293
(HEK293) cells were maintained in DMEM/F-12 (Invitrogen) supplemented with 10%
fetal bovine serum, 10 U/ml penicillin and streptomycin, and 2 mM L-glutamine. Cells
were transiently transfected with 3.0ug of GFP-Kv1.3/-Flag or GFP-Kv1.3-∆TDV/-Flag
using the Lipofectamine LTX transfection reagent (Invitrogen). Confluent transfected
cultures were plated to a low density (25,000 cells/cm2) onto poly-D-lysine-coated tissue
culture plates (Corning Glass Works) and subsequently placed in serum-free medium
overnight for experimentation the following day.
Mutagenesis– All mutagenesis reactions were performed using the Quickchange
Lightning Site-Directed Mutagenesis Kit (Strategene), following the manufacturer’s
protocol. The GFP-Kv1.3-∆TDV truncation was created by inserting two premature stop
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codons into the wild-type channel using the following primer sequence and its reverse
complement:

5’-GTCAACATCATCAAAAAGATATTCTGATGAACTGA

TGTCTAATAGGGATCCACC-3’. Similar to previous reports (Panyi et al., 2003; Panyi
et al., 2004a), the Flag epitope was created by inserting the amino acid sequence,
DYKDDDDK, into the first extracellular loop of GFP-Kv1.3/-∆TDV and incorporating
D222 as the first aspartic acid residue in the Flag epitope using the following primer
sequence

and

its

reverse

complement:

5’-

TCTCCGTCGCAGGACTACAAGGACGACGACGACAA GGTGTTTGAGGCTGCC3’.
Immunofluorescence– To detect Kv1.3 on the cell surface, transiently transfected
HEK293 cells were live labeled with anti-Flag M2 antibody (1ug/mL; Sigma) at 37°C for
15 min. Cells were then rinsed 3 x 5 min in PBS, fixed in 4% formaldehyde in PBS for
20 min, and subsequently permeabilized with acetone for 5 min and rinsed in PBS. Cells
were then blocked for 20 min at 37°C in 3% goat serum, 0.1% fish skin gelatin in PBS.
Cells were incubated 20 min at 37°C in a rabbit polyclonal GM130 antibody (0.7 μg/mL;
Calbiochem), raised against recombinant protein containing amino acids 371-990 of
human GM130 (Lot # D00004465), to identify the Golgi apparatus and subsequently
rinsed 3 x 5 min in PBS. Alexa Fluor goat anti-mouse (647 nm) and goat anti-rabbit (568
nm) secondary antibodies (4.0

g/ml; Invitrogen) were applied for 20 min at 37°C and

all samples were mounted using ProLong Gold antifade reagent (Invitrogen). All images
were taken using the Olympus IX70 microscope and DeltaVision Restoration Imaging
System (Applied Precision, LLC). Golgi Localization was quantified as follows: Golgi
region of interest (ROI) was defined using the GM130 marker, and the amount of GFP96

Kv1.3 signal intensity present in the Golgi ROI was expressed as a percent of the total
GFP-Kv1.3 signal for the entire cell ((GFP-Kv1.3 in Golgi region / Total GFP-Kv1.3) X
100). Surface expression was quantified as follows: the intensity of the live labeled antiFlag M2 antibody was normalized to the total GFP-Kv1.3-Flag intensity of the cell
(surface Kv1.3/ total Kv1.3).
Immunoblot Analysis - Cells were washed with ice-cold phosphate-buffered saline and
lysed in radioimmune precipitation assay buffer (50 mM Tris, 150 mM NaCl, 11 mM
EDTA, 0.25% deoxycholate, 1% Nonidet P-40, 10% glycerol, 1 mM NaF, 1 mM
Na3VO4, 1 mM Na4 BAPTA, 1mM dithiothreitol, protease inhibitors (Sigma, catalog no.
P8340), phosphatase inhibitors (Calbiochem, catalog nos. 524624 and 524625), pH 8.0).
The lysate was centrifuged at 20,000 x g for 5 min, and the resulting supernatant was
combined with sample buffer and separated by SDS-PAGE. Western blotting detection of
Kv1.3 was done with anti-Kv1.3 monoclonal antibody (0.42ug/mL; NeuroMab). A
monoclonal anti-GAPDH antibody (1.0ug/mL; Millipore) was used to control for loading
efficiency. Blots were imaged and quantified with the Odyssey infrared imaging system
(Li-Cor Biosciences).
Electrophysiology-Electrophysiological recordings were performed at room temperature,
utilizing the whole cell patch clamp technique. Data acquisition and analysis were
obtained using the Axopatch 200B (Axon Instruments) patch clamp amplifier and
pCLAMP 9.2 (Axon Instruments) software. Electrodes were pulled in two stages from
thin wall filament glass capillary tubing (Warner Instruments) and fire polished to a
resistance ranging from 1 – 2 MΩ. Voltage clamp recording solutions were as follows
(in mM): external (bath) solution 100 NaCl, 5.4 KCl, 1.8 CaCl2. 0.8 MgCl2, 23 glucose,
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5 Na Hepes, pH 7.4; internal (pipette) solution: 120 KCl, 3.69 CaCl2, 0.094 MgCl2, 5
BAPTA, 5 EDTA, 5 Na HEPES, 5 glucose, pH 7.2. Cells were held at -60 mV, followed
by a 20 ms hyperpolarization to -90 mV, and stepped from -70 mV to +50 mV in 10 mV
increments. Leak currents (P/8) were subtracted from all traces.

MBP Pulldown– pMAL-Kv1.3-C-term, pMAL-Kv1.3∆TDV-C-term, and the empty
pMAL vector were transformed into BL21 Gold bacterial cells (Strategene). Cultures
were grown in LB supplemented with Glucose/Ampicillin and protein expression was
induced by adding 0.3mM IPTG for 2 hours. Cells were harvested at 4000x g for 10 min
and resuspended in Column Buffer (20mM Tris-HCl, 200mM NaCl, 1mM EDTA, 1mM
sodium azide, 1mM DTT). Cells were lysed and the protein extracts (MBP-Kv1.3, MBP∆TDV or MBP) were coated onto Amylose resin (New England Biolabs). HEK293 cells
transfected with pGW1-CMV-myc-PSD-95 were lysed in RIPA and precleared with
MBP coated Amylose resin by rocking for 30 min at 4°C. Precleared myc-PSD-95
lysates were then rocked with either MBP-Kv1.3, MBP-∆TDV or MBP coated Amylose
resin for 30 min at 4 °C, washed 3x in RIPA, needle aspirated, combined with sample
buffer and separated by SDS-PAGE. Western blotting detection of myc-PSD-95 was
done with an anti-Myc monoclonal antibody (0.1 ug/mL; Invitrogen) and Kv1.3 was
detected using an anti-Kv1.3 monoclonal antibody (0.42 ug/mL; NeuroMab). Blots were
imaged and quantified with the Odyssey infrared imaging system (Li-Cor Biosciences).
Statistical Analysis - Data are presented as means ± standard errors. As noted, either
nonparametric Man-Whitney U tests, unpaired Student’s t-tests assuming unequal
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variances, or one-way ANOVA with post hoc Bonferroni test were used to determine
statistical differences. Differences were considered significant if p ≤ 0.01.
Results
Golgi localization of Kv1.3- Previous studies have shown that Kv1.3 is localized to the
Golgi apparatus in postganglionic sympathetic neurons (Doczi et al., 2008). The present
study explores the role of Kv1.3 Golgi localization on channel function using HEK293
cells as a model system. To determine the degree of Kv1.3 concentration in the Golgi
apparatus, cells were transfected with GFP-Kv1.3, processed for immunofluorescence
and labeled with the Golgi apparatus marker, anti-GM130, to delineate the Golgi region.
For each cell, GFP-Kv1.3 intensity was measured in two regions of interest: one
encompassing the entire cell (total Kv1.3) and one in the Golgi region (Golgi Kv1.3).
Golgi localization (%) was calculated as ((Golgi Kv1.3 / total Kv1.3) X 100). Figure 1A
illustrates that Kv1.3 has a distribution in the Golgi compartment ranging from 8.4 % to
50 %, with a mean Golgi localization of 28.5 % ± 3.1 (n = 20). The photomicrographs in
Fig 1B were selected to depict GFP-Kv1.3 transfected cells exhibiting Golgi localization
in both the upper range above the mean (46.0%; top) and the lower range below the mean
(9.6%; bottom).
The Golgi distribution of Kv1.3 is distinct from that observed with a closely
related channel, Kv1.2 (Fig. 1A). The mean Golgi localization of GFP-Kv1.2 (12.6 % ±
0.85; n = 20) was significantly less than mean Golgi localization of GFP-Kv1.3 (28.5% ±
3.1; n = 20; p < 0.0001). A representative photomicrograph depicting the intracellular
distribution of Kv1.2 is shown in Figure 1C. These data suggest that the high Golgi
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enrichment of GFP-Kv1.3 is a property of the channel itself, and is not a general property
of Kv1 channels expressed in HEK293 cells.

Kv1.3 surface expression is inversely related to Golgi localization of the channelIn addition to enrichment in the Golgi apparatus, Kv1.3 is also present in the plasma
membrane (Doczi et al., 2008). Because anterograde trafficking of proteins to the plasma
membrane can be regulated at the level of the Golgi apparatus, we hypothesized that
Kv1.3 Golgi localization may be a determinant of Kv1.3 surface expression. To measure
the amount of GFP-Kv1.3 localized to the plasma membrane, we introduced a FLAG
epitope (DYKDDDDK) into the extracellular loop between S1 and S2 transmembrane
helices (GFP-Kv1.3-Flag). Electrophysiological studies shown in Figure 2 confirm no
significant difference between B) the outward current or C) the half activation voltage of
GFP-Kv1.3 (open symbols) and GFP-Kv1.3-Flag (closed symbols).
To determine if Golgi localization of Kv1.3 influences its surface expression, we
quantified each parameter within the same cell. Fluorescence microscopy was used to
measure total Kv1.3 protein and immunofluorescence analysis was used to measure Golgi
localized Kv1.3 and surface Kv1.3. Surface Kv1.3 was labeled by applying anti-Flag M2
antibody to live cells. The representative photomicrographs shown in Figure 2B illustrate
a cell transfected with GFP-Kv1.3-Flag (green) and live labeled with anti-Flag-M2 (blue)
to detect the extracellular Kv1.3-Flag epitope. The restriction of Flag signal to the plasma
membrane, and the absence of Flag signal in the Golgi apparatus, confirmed the anti-Flag
M2 antibody had access only to channel at the cell surface. To quantify Kv1.3 surface
expression, the intensity of the live labeled anti-Flag M2 antibody was normalized to the
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total GFP-Kv1.3-Flag intensity of the cell (surface Kv1.3/ total Kv1.3). Linear regression
analysis revealed that Kv1.3 surface expression was inversely correlated with Golgi
localization of the channel (R-squared = 0.56; n = 82) (Fig 2D). These data indicate that
cells with increased Kv1.3 Golgi localization exhibit decreased expression of the channel
at the cell surface, suggesting the Golgi apparatus may serve as an internal reservoir for
the channel.
To facilitate analysis, cells were binned into two categories based on their
distribution relative to the median percent Golgi localization. Cells are described as
having high or low Kv1.3 Golgi localization if the percent channel Golgi localization
falls above or below the median, respectively. Figure 2E depicts the surface expression of
GFP-Kv1.3-Flag channels exhibiting high or low Golgi localization. The median Golgi
localization for GFP-Kv1.3-Flag transfected cells was 15.9%. Figure 2E demonstrates the
normalized surface expression (Kv1.3 surface/Kv1.3 total) of GFP-Kv1.3-Flag in the low
Golgi localized population (n = 41; mean = 2.2 ± 0.12) was significantly higher than the
surface expression of the high Golgi localized Kv1.3 population (n = 41; mean = 1.0 ±
0.10; p < 0.01) (Fig 2E).

Golgi localization and Kv1.3 ionic current- We next asked if the increase in
surface expression of Kv1.3 is a determinant of channel function. Since Kv1.3 Golgi
localization was inversely correlated with surface expression, we tested the hypothesis
that a similar relationship exists between Kv1.3 Golgi localization and Kv1.3 ionic
current. Because electrophysiological recordings were performed in live cells, we
visually categorized GFP-Kv1.3 transfected cells as having either high or low Golgi
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localization before each recording. To confirm that visual categorization parallels the
previous immunofluorescence data (Fig 2E), we conducted a blind assay to assign
previously captured photomicrographs of GFP-Kv1.3-Flag transfected cells into high and
low Golgi localized bins. The results of that visual categorization were then compared to
the quantitative categorization. Visual categorization correctly binned 79.3% of cells into
their respective high Golgi localized (above the median) and low Golgi localized (below
the median) category. No high Golgi cells were incorrectly identified as low Golgi.
Therefore any inaccurate visual categorization would only underestimate the significance
of the data presented.
Steady-state ionic current was measured from cells visually categorized as having
high (Fig 3A) or low (Fig 3B) channel localization to the Golgi apparatus. The traces
depicted in Figure 3 represent the average outward current recorded from cells in each
category. Steady-state current voltage relationships were plotted for cells exhibiting both
high (closed symbols) and low (open symbols) Kv1.3 Golgi localization (Fig 3C). The
outward current from cells categorized as having high Kv1.3 Golgi localization (18.2 nA
± 2.1; n = 15) was significantly lower than cells categorized as having low Kv1.3 Golgi
localization (26.0 nA ± 2.4; n = 12; p < 0.05). There was no significant difference in the
voltage dependence of high and low Golgi localized Kv1.3 channels (Fig 3D), indicating
that the increase in outward current was not due to a decreased voltage dependence of
channel activation. These data suggest that Kv1.3 ionic current may depend on Golgi
localization of the channel.

102

Disrupting the C-terminal PDZ binding motif of Kv1.3 decreases Golgi localization of
the channel- The C-terminal region of Kv1.3 contains a PDZ- binding motif which is
known to associate with PDZ domain containing proteins, aiding in localization and
function of the channel to various cellular compartments (Marks and Fadool, 2007). To
determine the importance of this motif in Kv1.3 Golgi localization, we created a
truncated form of the channel lacking the last three amino acids (∆TDV). Equal amounts
of GFP-Kv1.3-WT (WT) and GFP-Kv1.3-∆TDV (∆TDV) were separately transfected
into HEK293 cells and immunoblot analyses indicate no significant difference in total
channel protein (Fig 4A). Both WT and ∆TDV bands were detected at the expected
molecular mass of 100-kDa. Equal loading was confirmed by normalizing both WT and
∆TDV band densities to glyceraldehyde-3 phosphate dehydrogenase (GAPDH). There
was no significant difference in the corresponding mean densitometry between WT (n =
8; 1.0 ± 0.7) and ∆TDV (n = 8; 0.92 ± 0.14; p = 0.29).
To confirm that the ∆TDV truncation successfully disrupted the PDZ binding
motif of Kv1.3 and abolished the binding of PDZ domain containing proteins, we
performed a standard pulldown assay using PSD-95, a canonical PDZ domain containing
protein known to bind to Kv1.3 (Kim et al., 1995; Marks and Fadool, 2007). The pMALKv1.3-C-term construct was used to express Maltose Binding Protein (MBP) fused to the
C-terminal region of Kv1.3. In addition to MBP-Kv1.3-C-term (WT), two other fusion
proteins were created: MBP-Kv1.3- ∆TDV (∆TDV) and a MBP-only (MBP) control.
MBP, WT, and ∆TDV coated beads were incubated with HEK293 cell lysates containing
myc-PSD95. Figure 4B illustrates that PSD95 binds to the C-terminus of Kv1.3-WT and
that binding is abolished with the ∆TDV truncation.
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To address the hypothesis that the PDZ binding motif of Kv1.3 contributes to
Golgi localization of the channel, HEK293 cells were transfected with GFP-Kv1.3-∆TDV
(∆TDV) and processed for immunofluorescence. To quantify Golgi localization of
∆TDV, we used the Golgi apparatus marker, anti-GM130. Figure 4D illustrates that
Golgi localization of ∆TDV (11.12% ± 1.4; n = 20) was significantly less than WT
(28.5% ± 3.0; n = 20; p < 0.0001). In fact, all ∆TDV data points fell below the WT mean
(Fig 4D). The representative photomicrograph in Fig 4C depicts the intracellular
localization of Kv1.3-∆TDV (9.8%). These data show that removal of the PDZ binding
motif of Kv1.3 decreases Golgi localization of the channel and suggest that this motif
may be involved in the Golgi-mediated regulation of the channel.

Disrupting the C-terminal PDZ binding motif of Kv1.3 increases outward functional
current and plasma membrane expression of the channel- We next tested the hypothesis
that the PDZ binding motif of Kv1.3 contributes not only to Golgi localization, but also
surface expression and Kv1.3 channel function. Steady-state outward current was
measured from GFP-Kv1.3-Flag-WT transfected cells exhibiting both high (15.5 mV ±
0.78; n = 15) and low (9.2 mV ± 0.77; n = 15) channel Golgi localization (Figure 5A and
B). Recordings from both high and low Golgi localized GFP-Kv1.3-Flag-WT
demonstrate increased outward current in the low Golgi localized cells. This finding
parallels the previous electrophysiological data for GFP-Kv1.3 (Fig 3) and indicates that
introducing the Flag epitope does not alter the significant difference in current between
the high and low Kv1.3 Golgi localized cells. Since we found that the ∆TDV truncation
decreased Golgi localization of Kv1.3, we hypothesized that deleting this PDZ binding
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motif would more closely represent the current conducted from the low Golgi localized
Kv1.3 channels and in turn increase outward functional current. Steady-state outward
current measured from GFP-Kv1.3-Flag-∆TDV (16.1 mV ± 1.0; n = 27) transfected
HEK293 cells indicate that the channel is functional and that disrupting the PDZ binding
motif significantly increases Kv1.3 outward current (Fig 5C). The corresponding current–
voltage relationships (Fig 5D) for high and low Golgi localized GFP-Kv1.3-Flag-WT and
GFP-Kv1.3-Flag-∆TDV (∆TDV) demonstrate that outward current recorded from the
∆TDV channels is significantly higher than high Golgi localized WT Kv1.3. There is no
significant difference between outward current of ∆TDV and the low Golgi localized WT
Kv1.3 channel. Activation curves for high and low Golgi localized WT and ∆TDV were
plotted from tail currents and fit to a Boltzmann equation to determine the half activation
voltages (V1/2) for each channel (Fig. 5E). No significant difference was observed in the
V1/2 for WT (-20.7 mV ± 1.4; n = 15) and ∆TDV (-21.2 ± 0.94; n = 27; p > 0.05)
channels, indicating that the increase in ∆TDV current is not due to alterations in voltage
dependence.
To test the hypothesis that the observed increase in Kv1.3 current is due to
increased channels at the cell surface, we performed an immunofluorescence assay to
measure both Golgi localization and surface expression of GFP-Kv1.3-Flag-∆TDV
transfected HEK293 cells. Similar to the non Flag construct, the Golgi localization of
GFP-Kv1.3-Flag-∆TDV (11.6% ± 0.57; n = 59) was significantly less than GFP-Kv1.3Flag-WT (21.7% ± 1.6; n = 82; p < 0.0001). For the purpose of comparison, the GFPKv1.3-Flag-WT surface expression data from Figure 2E is shown. As described earlier,
the WT population was binned into two categories, high and low, based on median Golgi
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localization (16.0%). A one-way ANOVA followed by post hoc Bonferroni test for
multiple comparisons revealed the normalized surface expression of GFP-Kv1.3-Flag∆TDV (n = 59; mean = 1.6 ± 0.11) was significantly higher than surface expression of
high Golgi GFP-Kv1.3-Flag-WT (n = 41; mean = 1.0 ± 0.10; p < 0.0001) and lower than
low Golgi GFP-Kv1.3-Flag-WT (n = 41; mean = 2.2 ± 0.12; p > 0.05), suggesting that
the ∆TDV truncation decreases Golgi localization of Kv1.3, while increasing surface
expression of the channel. Coupled with the increase in ionic current, these data also
suggest the PDZ binding-motif disruption-mediated increase in Kv1.3 plasma membrane
expression may involve a novel mechanism for anterograde Golgi trafficking of the
channel.

Discussion

Subcellular localization and trafficking are distinct properties that have been
shown to extensively influence ion channel function (Lai and Jan, 2006). In this study,
we have shown that Kv1.3 is enriched in the Golgi apparatus and that the degree of this
enrichment is inversely correlated with the amount of channel in the plasma membrane.
Removal of the C-terminal PDZ-binding motif of Kv1.3 decreases Golgi localization and
increases channel at the cell surface. In turn, this decrease in Golgi localization is
accompanied by an increase in Kv1.3 ionic current. We propose that retention of Kv1.3
in the Golgi apparatus is a mechanism for regulating the amount of functional Kv1.3
channels at the cell surface (Fig 6).
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Biosynthetic trafficking is an important mechanism for determining the level of
mature protein within a cell and can be regulated at multiple stages. Although several
motifs exist for modulating the endoplasmic reticulum (ER) retention and export of
potassium channels (Zarei et al., 2004; Zhu et al., 2005; Zhu et al., 2003a, b), the Golgi
apparatus may also serve as a checkpoint for anterograde protein trafficking (Cheng et
al., 2002; Gentzsch et al., 2003; He et al., 2002). We show that disrupting the PDZbinding motif of Kv1.3 significantly decreases the amount of Kv1.3 channel in the Golgi
apparatus (Fig 4), suggesting that PDZ-mediated interactions may contribute to the
regulated biosynthetic trafficking of this channel. Disrupting the PDZ-binding motif of
Kv1.3 also increases the amount of channel at the cell surface and the amount of Kv1.3
ionic current (Fig 5), supporting the idea that Golgi retention serves as a checkpoint for
regulating Kv1.3 channel activity. The ∆TDV mutation increased surface expression of
Kv1.3 by 60.0%, and increased Kv1.3 ionic current by 75.0%. These increases could
result from a separate mechanism for regulating Kv1.3 channel at the plasma membrane.
This is consistent with previous studies demonstrating that posttranslational modification
of Kv1.3 can lead to alterations in Kv1.3 ionic current. For example, phosphorylation of
Kv1.3 by cellular and receptor tyrosine kinases has been shown to induce current
suppression of the channel (Bowlby et al., 1997; Colley et al., 2004; Fadool et al., 1997;
Holmes et al., 1996; Marks and Fadool, 2007; Tucker and Fadool, 2002). In addition,
protein interactions have also been shown to modulate Kv1.3 activity. Coexpression of
the synaptic adaptor protein, PSD-95, significantly suppresses Kv1.3 peak current
magnitude in a use-dependent fashion (Marks and Fadool, 2007). Therefore, separate
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mechanisms of Kv1.3 channel modulation at the plasma membrane may alter the function
of the channel without affecting surface expression.
The notion that Kv1.3 Golgi localization serves as a checkpoint for regulating
Kv1.3 function is also consistent with our observation that Kv1.3 Golgi localization is
variable in HEK293 cells (Fig 1). The reason for this cell to cell variability is currently
not known, however it could result from differences in steady-state signaling profiles
between cells, resulting in altered effects on PDZ interactions. Many class I PDZ-binding
motifs (X-S/T-X-Φ) are susceptible to posttranslational modifications that may alter the
interaction of these motifs with PDZ domain containing proteins (Arnold and Clapham,
1999; Ikenoue et al., 2008; Lin et al., 2006; Matsuda et al., 1999). For example,
phosphorylation of these motifs via specific serine/threonine kinases has been shown to
perturb protein-protein interactions. Phosphorylation of AMPA receptor GluR2 subunits
by PKC can reduce the receptor binding affinity for GRIP, a synaptic PDZ domaincontaining protein (Matsuda et al., 1999). Similarly, casein kinase II can phosphorylate
the NR2B subunit of NMDA receptors and disrupt the interaction of NR2B with both
PSD-95 and SAP102, in turn decreasing surface expression of this receptor (Lin et al.,
2006). Alternatively, acetylation of a lysine residue present in the PDZ-binding motif of
PTEN has been shown to play a role in mediating PDZ domain interactions (Ikenoue et
al., 2008). Therefore, posttranslational modification of the Kv1.3 PDZ-binding motif may
alter protein-protein interactions and contribute to the observed variability of Kv1.3 Golgi
localization in HEK293 cells.
Other Kv1 family channels also contain similar PDZ-binding motifs, although the
mechanisms of channel regulation differ considerably (Kim et al., 1995). We found that
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Kv1.2, which also contains a C-terminal PDZ-binding motif, did not display the same
degree of Golgi localization as Kv1.3 (Fig 1). These results are consistent with reports
indicating that subcellular distribution of Kv1.2 is mainly in the endoplasmic reticulum
(ER) and highlight a fundamental difference between two closely related channels of the
same family (Shi and Trimmer, 1999). These differences in intracellular distribution may
reflect differences in the various trafficking pathways involved in channel regulation. For
instance, cyclic AMP-mediated increases in plasma membrane Kv1.2 have been shown to
be independent of Golgi trafficking (Connors et al., 2008); Modulated endocytosis at the
plasma membrane is a major determinant of Kv1.2 activity at the cell surface (Nesti et al.,
2004). In contrast to Kv1.2, our data suggest that the Golgi apparatus may function as a
reservoir for Kv1.3 channel regulation. Overall, our findings suggest an additional,
trafficking dependent mechanism for regulating Kv1.3 function in the cell, which exists
in parallel with other mechanisms of channel regulation.
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Figure Legends

Figure 1: Intracellular distribution of Kv1.3. A) Vertical scatter plot depicting the
mean Golgi localization (%) and distribution of both GFP-Kv1.3 (n = 20; mean = 28.5%
± 3.1) and GFP-Kv1.2 (n = 20; mean = 12.6 % ± 0.85) transfected HEK293 cells. GFPKv1.2 Golgi localization is significantly decreased compared to GFP-Kv1.3 (p <0.0001,
Mann-Whitney test) B) Representative photomicrographs of HEK293 cells transfected
with GFP-Kv1.3 (green) demonstrate a differential intracellular distribution of the
channel. Each photomicrograph is an example of a cell in the range above (46.0%) and
below

(9.6%)

the

mean

GFP-Kv1.3

Golgi

localization.

B)

Representative

photomicrograph of an HEK293 cell transfected with GFP-Kv1.2 (green) demonstrates a
decreased percentage of this channel (13.0%) detected in the Golgi region. The GM130
marker (red) was used to define the Golgi region. Scale bar = 10 μm.

Figure 2: Kv1.3 surface expression is inversely related to Golgi localization of the
channel.

A) Steady-state current-voltage relationships for GFP-Kv1.3 (open symbols)

and GFP-Kv1.3-Flag (closed symbols) indicate no difference in channel function due to
the presence of the extracellular Flag epitope. B) Activation curves plotted from the tail
current of GFP-Kv1.3 (open symbols) and GFP-Kv1.3-Flag (closed symbols) indicate no
difference in voltage sensitivity due to the presence of the extracellular Flag epitope. C)
Representative photomicrograph of an HEK293 cell transfected with GFP-Kv1.3-Flag
(green) and live labeled with anti-Flag-M2 (blue) to detect the extracellular Kv1.3-Flag
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epitope, and thus Kv1.3 at the cell surface. After fixation, cells were labeled with antiGM130 (red) to define the Golgi region and to subsequently calculate Golgi localization
(GFP-Kv1.3 in Golgi region / Total GFP-Kv1.3). D) Scatter plot depicting the
relationship between Kv1.3 surface expression and Golgi localization for GFP-Kv1.3Flag. Linear regression analysis indicates that Kv1.3 surface expression is inversely
correlated with Golgi localization of the channel (n = 82; R-squared = 0.56). E)
Normalized surface expression of GFP-Kv1.3-Flag transfected HEK293 cells. Kv1.3 was
binned into categories based on Golgi localization above (high; black bar) or below (low;
white bar) the mean value (21.7%). Surface expression was calculated (anti-Flag-M2 /
total GFP-Kv1.3-Flag) and both the high and low Golgi values were normalized to the
mean value for cells exhibiting high GFP-Kv1.3-Flag Golgi localization. Surface
expression of the low Golgi localized GFP-Kv1.3 population (n = 54; mean = 2.2 ± 0.12)
is significantly higher than surface expression of the high Golgi localized GFP-Kv1.3
population (n = 28; mean = 1.0 ± 0.10; p < 0.0001; unpaired t-test). Scale bar = 10 μm .

Figure 3: Kv1.3 ionic current is inversely related to Golgi localization of the
channel. Ionic current evoked by stepped voltages from -70 to + 50 mV in GFP-Kv1.3
transfected HEK293 visually categorized as having A) high or B) low Golgi localization.
Visual categorization was confirmed by blind assessment of Golgi localization, yielding
zero false low Golgi localized channels. Current traces are averages of currents from
multiple cells (n ≥ 12). C) Steady-state current-voltage relationships for GFP-Kv1.3 in
cells categorized as having high (closed symbols) or low (open symbols) Golgi
localization. Ionic current was significantly greater in cells categorized as having low
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Kv1.3 Golgi localization. (*P ≤ 0.05; unpaired t-test). D) Activation curves plotted from
the tail current indicate no difference in channel voltage sensitivity in cells categorized as
having high (closed symbols) and low (closed symbols) Kv1.3 Golgi localization.

Figure 4: Disrupting the C-terminal PDZ binding motif of Kv1.3 decreases Golgi
localization of the channel. A) Representative immunoblots and corresponding
normalized immunodensitometry demonstrating no significant difference in protein
expression of GFP-Kv1.3-WT (WT; mean = 1.0 ± 0.08) and GFP-Kv1.3-∆TDV (∆TDV;
mean = 0.92 ± 0.14) in cells transfected with equal amounts of plasmid DNA (n = 8; p >
0.05). GAPDH indicates equal loading between lanes and was used to normalize Kv1.3
band intensities. B) Immunoblot of eluant from an in vitro maltose binding protein
(MBP) pulldown assay of lysates from HEK 293 cells transiently transfected with mycPSD-95. Protein was collected with beads coated with either an MBP only control, MBP
fused to the C-terminus of Kv1.3-WT (WT) or Kv1.3-∆TDV (∆TDV). Blots were probed
with anti-Myc antibody (top) or anti-Kv1.3 C-term antibody (bottom). Removal of the
PDZ binding motif of Kv1.3 abolishes the channels ability to pull down the canonical
PDZ domain protein, PSD-95. C) Representative photomicrograph of an HEK293 cell
transfected with GFP-Kv1.3-∆TDV (green) and labeled with the Golgi apparatus marker,
GM130 (red; n = 20). D) Vertical scatter plot depicting the Golgi localization (%) and
distribution of GFP-Kv1.3 (WT) and GFP-Kv1.3-∆TDV (∆TDV) expressed in HEK293
cells. For the purpose of comparison, the GFP-Kv1.3 (WT) data from Figure 1A is
shown. The ∆TDV truncation (n = 20; mean = 11.1 ± 1.39) significantly decreased Kv1.3
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Golgi localization compared to WT channel (n = 20; mean = 28.5% ± 3.1; Mann-Whitney
test; p < .0001). Scale bar = 10μm

Figure 5: Disrupting the C-terminal PDZ binding motif of Kv1.3 increases ionic
current and plasma membrane expression of the channel. Ionic current measured in
HEK 293 cells transfected with GFP-Kv1.3-Flag-WT and visually categorized as having
A) high or B) low Kv1.3 Golgi localization. C) Ionic current measured in HEK 293 cells
transfected with GFP-Kv1.3-Flag-∆TDV (∆TDV). Current traces for each condition are
the average of currents from multiple cells (n ≥ 15). D) Steady-state current-voltage
relationships for GFP-Kv1.3-Flag-WT exhibiting high (open diamonds; n = 15; mean =
9.2 mV ± 0.8) and low (open triangles; n = 15; mean = 15.5 mV ± 0.8) Golgi localization,
as well as GFP-Kv1.3-Flag-∆TDV (closed squares; n = 27; mean = 16.1 mV ± 1.0)
demonstrate a significant difference between WT high Golgi and ∆TDV (P ≤ 0.02;
unpaired t-test). No difference in ionic current was detected between WT low Golgi and
∆TDV. E) Activation curves plotted from the tail current indicate no difference in
channel voltage sensitivity in cells expressing GFP-Kv1.3-Flag-WT exhibiting high
(open squares) and low (open triangles) Golgi localization and GFP-Kv1.3-Flag-∆TDV
(closed squares). F) GFP-Kv1.3-Flag surface expression in cells categorized as having
high (n = 28; mean = 1.0 ± 0.10) or low (n = 54; mean = 2.2 ± 0.12) Golgi localization,
compared to surface expression of GFP-Kv1.3-∆TDV (∆TDV; n = 59; mean = 1.6 ±
0.11). ∆TDV surface expression is significantly higher than surface expression of the
WT high Golgi localized population (p < 0.0001).
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Figure 6: Proposed model for Kv1.3 regulation. As Golgi localization of Kv1.3
increases, both surface expression and ionic current decrease, a trend potentially
mediated by the C-terminal PDZ-binding motif of the channel. Conversely, as Kv1.3
Golgi localization decreases, both surface expression and ionic current increase,
suggesting increased channel activity at the cell surface in response to disrupting the
PDZ-binding motif.
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Figure 1: Intracellular distribution of Kv1.3.
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Figure 2: Kv1.3 surface expression is inversely related to Golgi localization of the
channel.
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Figure 3: Kv1.3 ionic current is inversely related to Golgi localization of the
channel.
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Figure 4: Disrupting the C-terminal PDZ binding motif of Kv1.3 decreases Golgi
localization of the channel.
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Figure 5: Disrupting the C-terminal PDZ binding motif of Kv1.3 increases ionic
current and plasma membrane expression of the channel.
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Figure 6: Proposed model for Kv1.3 regulation.
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CHAPTER 4: COMPREHENSIVE DISCUSSION

Ion channels are key determinants of excitability in multiple cell types, including
neurons (Schauf and Bullock, 1979). The localization of these ion channels to distinct
cellular compartments greatly influences various components of neuronal function such
as resting membrane potential, action potential characteristics and neurotransmission
(Chiu and Ritchie, 1981; Lai and Jan, 2006; Rasband et al., 1998). Thus, understanding
the regulatory mechanisms governing ion channel localization can provide fundamental
insight into human physiology. The main goal of this dissertation was to elucidate the
localization, function, and regulation of the voltage-gated potassium channel, Kv1.3. The
experiments outlined in Chapter 2 of this study reveal the novel role of Kv1.3 as a
determinant of sympathetic neuronal activity. In addition to plasma membrane
expression, Kv1.3 also exhibited intracellular localization to the Golgi apparatus in these
neurons. Using a model cell system, the data presented in Chapter 3 reveal a role for the
PDZ-binding motif in mediating this Golgi localization of Kv1.3. Collectively, this
research emphasizes how channel localization can influence the functional importance of
Kv1.3 and suggests a new mechanism of channel regulation.
In Chapter 2, we used neurons from the sympathetic branch of the autonomic
nervous system as a model to study endogenous Kv1.3. Previous research showed that
Kv1 channel mRNA was present in superior cervical ganglia (Dixon and McKinnon
1996). In addition, previous reports demonstrated that using 4-aminopyridine to block
Kv1 family channels in postganglionic sympathetic neurons increased neurotransmitter
release (Ikushima et al., 1981; Uhrenholt and Nedergaard, 2003). However, the specific
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ion channels involved remained largely unexplored. We found that sympathetic neurons
express Kv1.3 protein and that the channel is localized to both the soma and processes
(Chapter 2, Figure 1). Kv1.3 ionic current was also pharmacologically isolated from the
soma, indicating that the channel is a determinant of the electrophysiological properties
of these cells (Chapter 2, Figure 4). Extensive work in T lymphocytes has identified
Kv1.3 as a major determinant in the regulation of resting membrane potential (Deutsch
and Chen, 1993; Koo et al., 1997; Lin et al., 1993; Mello de Queiroz et al., 2008).
Through mechanisms involving membrane depolarization and the subsequent attenuation
of Ca+2 influx, selective Kv1.3 blockade suppresses the signaling cascades that lead to T
lymphocyte activation and proliferation (Koo et al., 1997; Lin et al., 1993). In this study,
we show that Kv1.3 also influences the resting membrane potential and function of
postganglionic sympathetic neurons; inhibition of the channel depolarizes resting
membrane potential, decreases the latency to action potential firing, and increases
nicotinic agonist-induced neurotransmitter release (Chapter 2, Figures 5 and 7).
The research presented in Chapter 2 is the first demonstration that Kv1.3
contributes to sympathetic neuronal function and provides evidence that regulating Kv1.3
conductance can modulate neuronal excitability. Muscarinic acetylcholine receptor
(mAChR) activation has previously been shown to suppress other K+ channels, namely
Kv1.2 (Huang et al., 1993; Lechner et al., 2003). Initial studies exploring Kv1.2
regulation found that mAChR activation led to suppression of the channel’s ionic current
(Huang et al., 1993). The primary preganglionic input to postganglionic neurons is
acetylcholine (ACh) and our studies present novel evidence that Kv1.3 current can also
be modulated through mAChR activation (Chapter 2, Figure 6). Although tyrosine
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phosphorylation-induced endocytosis has been defined as the mechanism for Kv1.2
current suppression (Huang et al., 1993), and Kv1.3 ionic current is also known to be
modulated via tyrosine phosphorylation (Holmes et al., 1996) , no direct evidence exists
to link mAChR activation to Kv1.3 trafficking events. Further studies may aim to
elucidate the mechanism of stimulus-induced Kv1.3 current suppression to determine
whether this phenomenon is dependent upon altered channel biophysics, potentially
resulting from conformational changes within the channel itself, or due to negative
trafficking of the channel away from the plasma membrane.
The unusual observation that Kv1.3 exhibits localization to a discrete
intracellular compartment (Chapter 2, Figures 2 and 3) led to the hypothesis that retention
of this channel in the Golgi apparatus may constitute a trafficking-dependent mechanism
of regulation. While it is known that Kv1.3 undergoes tyrosine phosphorylation-induced
current suppression at the plasma membrane (Holmes et al., 1996), no evidence exists
linking decreased current to trafficking events such as endocytosis. Therefore, exploring
the intracellular localization of Kv1.3 may provide evidence for an additional,
trafficking-dependent mechanism of channel regulation which may operate concurrently
with the biophysical regulation observed in other studies. Although similar intracellular
localization of Kv1.3 has been previously reported in other cell types such as the
HEK293 model cell system (Vicente et al., 2008a) and pyramidal neurons (Guan et al.,
2006), the work outlined in Chapter 3 is the first to quantify this Kv1.3 Golgi
localization. In addition, this study proposes a novel mechanism of channel regulation
that is PDZ-binding motif dependent. The third chapter of this dissertation is dedicated to
elucidating the role of Kv1.3 Golgi localization in channel function at the cell surface.
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We show that Kv1.3 channels expressed in HEK293 cells localize to the Golgi apparatus
with a high degree of variability (Chapter 3, Figure 1). Interestingly, the degree of this
Golgi localization is inversely correlated with surface expression of the channel,
suggesting the Golgi apparatus may serve as a checkpoint for the regulated trafficking of
Kv1.3 to the plasma membrane (Chapter 3, Figure 2).
Previous work indicates that other ion channels are also localized to the Golgi
apparatus (Cheng et al., 2002; Gentzsch et al., 2003). CFTR exhibits intracellular
accumulation in the Golgi where it associates with a Golgi resident PDZ domain protein
presumed to tether CFTR to this organelle and potentially regulate the channels transit to
the plasma membrane (Cheng et al., 2002). Another chloride channel, ClC-3B, also
localizes to the Golgi and has been found to associate with the same Golgi resident PDZ
domain proteins as CFTR (Gentzsch et al., 2003). These findings, coupled with the
knowledge that PDZ interactions play a major role in the localization and function of
many proteins (Sheng and Sala, 2001), led us to hypothesize that Golgi localization of
Kv1.3 may depend on protein associations with the C-terminal PDZ-binding motif of the
channel. Interestingly, disrupting the PDZ-binding motif of Kv1.3 eliminated the striking
intracellular localization of the channel to the Golgi apparatus, without altering the total
amount of Kv1.3 protein within the cell (Chapter 3, Figure 4). This decrease in Golgi
localization was accompanied by an increase in Kv1.3 ionic current (Chapter 3, Figure 5),
indicating a potential role for the PDZ-binding motif in such processes as the regulation
of Golgi retention-mediated channel trafficking to the plasma membrane or stabilization
of functional channels already at the cell surface. Subsequent analysis also reveals an

129

increase in the number of channels at the cell surface (Chapter 3, Figure 5), providing
evidence for a trafficking dependent mechanism of Kv1.3 channel regulation.
One possible mechanism for regulating Kv1.3 Golgi localization may involve
protein-protein interactions. In a native HEK23 cell system, endogenous proteins may
interact with the C-terminal PDZ-binding motif of Kv1.3 to retain this channel in the
Golgi. Deleting this motif may disrupt these protein interactions, leading to increased
channels at the cell surface and increased Kv1.3 ionic current. Further investigation may
identify associations with specific PDZ domain proteins and reveal a role for these
interactions in the anterograde trafficking pathways of the channel. While other members
of the Kv1 family also contain C-terminal PDZ binding-motifs, their specific primary
amino acid sequence varies (Kim et al., 1995). Previous studies have defined a role for
the amino acids upstream from the final C-terminal residue, termed P0, in the recognition
and binding of PDZ domain containing proteins (Jelen et al., 2003; Sheng and Sala,
2001). Other members of the Kv1 family contain either a glutamate or leucine residue at
the upstream P-3 position, which may be involved in mediating the selectivity of PDZ
interactions (Kim et al., 1995; Songyang et al., 1997). However, the P-3 position of Kv1.3
is occupied by phenylalanine, a nonpolar hydrophobic residue containing a large benzyl
side chain. Therefore, the distinct Golgi localization of Kv1.3 may be mediated by a PDZ
domain protein interaction whose specificity is dependent on this residue. The differences
in channel localization within the same family can be addressed with future experiments
including mutational analysis of specific amino acids, as well as constructing chimeric
channels exchanging C-terminal domains. Alternatively, similar PDZ domain proteins
may bind to the C-terminal sequence of Kv1 family channels; however, variability at
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other amino acid positions outside the PDZ-binding motif may alter interactions between
the binding of accessory proteins of a larger complex.
Our reports are consistent with recent work indicating that the PDZ domain
protein, PSD-95, suppresses the peak current magnitude of Kv1.3 over the course of
repeated stimulation (Marks and Fadool, 2007). However, Marks et al also report that a
phosphorylation-independent mutation of critical residues in the PDZ-binding motif of
Kv1.3 abolishes this PSD-95 induced activity-dependent current suppression. However,
no change in outward current between wild-type Kv1.3 and this PDZ mutation was
reported (Marks and Fadool, 2007). Because our study employs a truncated form of
Kv1.3 that lacks the phosphorylation site in the PDZ-binding motif, further investigation
may reveal a role for post translational modification of this motif in the modulation of
channel function at the plasma membrane.
The data presented in this dissertation indicate that disrupting the PDZ-binding
motif of Kv1.3 abolishes the binding of the channel to the canonical PDZ domain protein,
PSD-95, and suggest that disrupting this motif may also interfere with the binding of
other PDZ domain containing proteins involved in channel regulation. Additionally, we
demonstrate that disrupting the PDZ-binding domain of Kv1.3 also decreases the Golgi
localization of the channel. Although specific PDZ protein interactions in the Golgi have
yet to be identified for Kv1.3, future directions may be aimed at pinpointing associated
PDZ proteins responsible for regulating trafficking of the channel at the level of this
organelle. We speculate that disrupting the PDZ-binding motif of Kv1.3 would disrupt
the association of the channel with these Golgi resident PDZ proteins, in turn disrupting
the Golgi regulation of Kv1.3.
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Anterograde trafficking of Kv1.3 from the Golgi apparatus to the cell surface may
be a regulated process, introducing the possibility that localization of Kv1.3 to this
organelle may serve as a reservoir of readily releasable channel.

Posttranslational

modification of PDZ binding-motifs has been shown to mediate their interaction with
PDZ domain containing proteins (Chung et al., 2004; Matsuda et al., 1999). Therefore,
serine/threonine phosphorylation of the Kv1.3 PDZ binding motif may be a mechanism
for altering protein-protein interactions, in turn regulating the affinity of the channel for
Golgi resident PDZ domain proteins. Decreased binding of Kv1.3 to Golgi associated
PDZ proteins may lead to the regulated release of the channel from this compartment,
increasing the amount of channel available for plasma membrane targeting. Similar to the
phosphorylation-mediated disruption of protein interactions, the PDZ-binding motif
deletion described in this dissertation may also eliminate the binding of Kv1.3 to specific
Golgi resident PDZ proteins.
Neurons contain compartmentalized structures such as the soma, axons, dendrites
and presynaptic terminals (Dotti et al., 1988), components not present in HEK293 cells.
The later portion of this study uses HEK293 cells to explore the relationship between
intracellular Golgi localization of Kv1.3 and surface expression of the channel, however,
these cells can only be used to study channel trafficking to and from a
noncompartmentalized plasma membrane. A major determinant of neuronal function is
the localization and distribution of ion channels along neuronal processes (Chiu and
Ritchie, 1981; Lai and Jan, 2006; Rasband et al., 1998). Therefore, it is important not
only to consider the regulation of plasma membrane expression of Kv1.3, but also how
the spatial distribution of this channel can be modulated. Chapter 1 demonstrates that
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endogenous Kv1.3 in postganglionic sympathetic neurons is enriched in the Golgi
apparatus. Depending on the plasma membrane targeting of Kv1.3, regulated release of
this channel from the Golgi may have differential effects on cellular function. Increased
Kv1.3 in the somal plasma membrane compartment may lead to a hyperpolarization of
resting membrane potential. Alternatively, an increase in the number of channels targeted
to the axonal region may result in a faster rate of action potential repolarization.
Ultimately, the trafficking of Kv1.3 from the Golgi apparatus to various plasma
membrane compartments may decrease neuronal firing, shorten action potential duration
and attenuate neurotransmitter release from these cells. Because altering the distribution
of Kv1.3 in the neuronal membrane can have such widespread affects on neuronal
function, it is important to gain a broader understanding of the regulation of these
channels.
The experiments presented in this dissertation have several limitations. Although
HEK293 cells are a commonly used heterologous expression system for studying the
biophysical properties and trafficking pathways of cloned ion channels (Connors et al.,
2008; Marks and Fadool, 2007; Nesti et al., 2004; Vicente et al., 2008b), observations
made in this cell line require further investigation in more physiologically relevant
systems. It is important to note that the conclusions in Chapter 3 of this study are based
on data collected from exogenous ion channel expression in HEK293 cells. Although this
work has established a foundation for understanding the effect of localization on Kv1.3
function, future directions include manipulating endogenous Kv1.3 in primary neuronal
cell culture. In vitro neuronal manipulations, such as disrupting Kv1.3 protein-protein
interactions or RNA interference of endogenous channels, may provide insight into how
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these channels and their associations affect neuronal function is a more physiologically
relevant system. Furthermore, the present studies measure [H3]-norepinephrine release
from exogenously loaded neurons in cell culture in response to nAChR stimulation in the
presence of a Kv1.3 inhibitor. The dissociated neurons used in this method have been
subject to multiple enzymatic treatments which have altered them from their native state
and extracellular environment. The dissociation processes strips the neurons of their
axons and dendrites, therefore any neurite outgrowth in culture may have physiological
characteristics different from in vivo preparations. Furthermore, experimental
manipulation of exongenously loading these cultured cells with [H3]-norepinephrine may
have altered the physiological stores of endogenous norepinephrine, potentially
contributing to experimental error. While [H3]-norepinephrine release in this study is
measured as a percentage of total radiotracer loading, it is important to note that the
amount of exogenously introduced neurotransmitter may reflect more than the
endogenous norepinephrine stores, thereby creating a larger pool from which an
amplified release may be observed. Alternatively, this technique may be limited by cell to
cell variability in the rate and efficiency of neurotransmitter uptake, attenuating the
observed norepinephrine release in response to nAChR activation.
Because sympathetic neurons communicate with target tissues such as blood
vessels via the release of this neurotransmitter (Bennett et al., 2004; McLachlan, 2007),
measuring the change in circulating plasma norepinephrine in response to Kv1.3
inhibition in the intact animal can provide valuable information regarding the role these
channels

play

in

overall

sympathetic function without introducing

artificial

neurotransmitters. In addition, determining the direct effects of Kv1.3 blockade on
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arterial diameter and blood flow can provide greater insight into the role these channels
play in vivo. Furthermore, this study does not incorporate pharmacological agents to
disrupt Kv1.3 trafficking. Therefore, the complimentary approach of using protein
transport or microtubule assembly inhibitors for studying the effect of localization on ion
channel function would further aid in elucidating the mechanisms involved in Kv1.3
regulation.
An additional limitation of this study is the use of the venom-derived toxin,
MgTX, to inhibit Kv1.3. While the specificity of channel inhibition is dependent on toxin
concentration, discrepancies exist in defining this optimal range. An alternative approach
to inhibiting endogenous Kv1.3 with MgTX is incorporating an antisense strategy such as
RNA interference to eliminate Kv1.3 protein production within cultured cells. In terms of
future studies, MgTX application in vivo may not be an effective approach due to the
instability of peptide application in a living animal, as well as the inability to specifically
administer the peptide to select regions. For this reason, directed gene knockdown may
provide a more thorough understanding of the effects of chronically eliminating Kv1.3.
In summary, the work presented in this dissertation is the first to identify the
Kv1.3 voltage-gated potassium channel as a key determinant of sympathetic neuronal
activity. Initial studies sought to characterize the expression and function of Kv1.3 in
these neurons and in the process, revealed a novel pattern intracellular localization to the
Golgi apparatus. This work has identified a role for the PDZ-binding motif in mediating
Golgi localization, surface expression and function of Kv1.3, leading us to propose that
the regulated subcellular distribution of the channel is a determinant of Kv1.3 function.
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